Guangtao Li1,2,3, Yuchao He1,3, Hui Liu1,3, Dongming Liu2,3, Lu Chen2,3, Yi Luo1,3, Liwei Chen1,3, Lisha Qi3,4, Yun Wang1,3, Yingying Wang1,3, Yu Wang1,3, Linlin Zhan1,3, Ning Zhang1,3, Xiaolin Zhu5,6, Tianqiang Song7,8, Hua Guo9,10. 1. Department of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China. 2. Department of Hepatobiliary Cancer, Liver Cancer Research Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China. 3. National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. 4. Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China. 5. Department of Hepatobiliary Cancer, Liver Cancer Research Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China. zhuxiaolin@tjmuch.com. 6. National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. zhuxiaolin@tjmuch.com. 7. Department of Hepatobiliary Cancer, Liver Cancer Research Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China. tjchi@hotmail.com. 8. National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. tjchi@hotmail.com. 9. Department of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China. guohua@tjmuch.com. 10. National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. guohua@tjmuch.com.
Abstract
Evolutionarily conserved heat shock proteins are involved in the heat shock response of cells in response to changes in the external environment. In normal tissues, heat shock proteins can help cells survive in a rapidly changing environment. Likewise, in malignant tumors heat shock proteins may help tumor cells cope with external stresses as well as the stress of treatment. In this way they become accomplices of malignant tumors. Here we demonstrated for the first time that high expression of DNAJC24 (a heat shock protein) shortens survival in patients with HCC by immunohistochemical staining of 167 paired hepatocellular carcinomas and paraneoplastic tissues as well as data from public databases. In vitro experiments demonstrated that stimuli such as hypoxia, starvation and heat could upregulate DNAJC24 expression in HCC cells through transcriptional regulation of HSF2, and high expression of DNAJC24 in HCC cells could promote the proliferation and motility of HCC cells. In addition, we also verified that targeting DNAJC24 under normal culture conditions can affect the proliferation and autophagy of HCC cells by interfering with ammonia metabolism, thereby inhibiting the malignant progression of HCC. Overall, we suggested that DNAJC24 may become a new target for the treatment of HCC.
Evolutionarily conserved heat shock proteins are involved in the heat shock response of cells in response to changes in the external environment. In normal tissues, heat shock proteins can help cells survive in a rapidly changing environment. Likewise, in malignant tumors heat shock proteins may help tumor cells cope with external stresses as well as the stress of treatment. In this way they become accomplices of malignant tumors. Here we demonstrated for the first time that high expression of DNAJC24 (a heat shock protein) shortens survival in patients with HCC by immunohistochemical staining of 167 paired hepatocellular carcinomas and paraneoplastic tissues as well as data from public databases. In vitro experiments demonstrated that stimuli such as hypoxia, starvation and heat could upregulate DNAJC24 expression in HCC cells through transcriptional regulation of HSF2, and high expression of DNAJC24 in HCC cells could promote the proliferation and motility of HCC cells. In addition, we also verified that targeting DNAJC24 under normal culture conditions can affect the proliferation and autophagy of HCC cells by interfering with ammonia metabolism, thereby inhibiting the malignant progression of HCC. Overall, we suggested that DNAJC24 may become a new target for the treatment of HCC.
Primary liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer death worldwide [1]. Hepatocellular carcinoma (HCC) is the most common primary liver cancer, with a reported 5-year survival rate of 47–53% even in patients with early, small HCC (<3 cm) who undergo surgical resection [2, 3]. The poor prognosis of HCC remains a challenge due to high rates of metastasis and postoperative recurrence [4, 5]. Therefore, a deep understanding of the mechanisms underlying HCC progression and the development of new therapeutic strategies are urgently needed.Cancer cells inevitably encounter stress during tumor development [6]. These stresses include hypoxia [6], starvation [7], thermal stress [8], acidosis [9] and the therapeutic interventions, among others. Heat shock proteins (HSPs) are a group of highly conserved proteins that are produced in response to natural or unnatural stresses [10]. They can prevent apoptosis induced by mitochondrial outer membrane permeabilization, cytochrome c release, apoptosome assembly, caspase activation and TNF death receptors [11]. DNAJC24 is a member of the type III DNAJ/HSP40 subfamily, which has the most member of all human HSP families. Members of this subfamily, DNAJA1 [12], DNAJB1 [13], DNAJB8 [14], DNAJC6 [15], and DNAJC12 [16], have been found to have important functions in cancer development or serve as diagnostic biomarkers. However, the role of DNAJC24 in malignancy has never been reported.Therefore, in this study, we applied a combination of online data mining, high throughput “omics” technologies, biochemistry and molecular biology to investigate the role and underlying mechanisms of DNAJC24 in HCC.
Materials and methods
Patients and tissue specimens
A total of 167 pairs of cancerous and matched adjacent nonmalignant tissue samples were obtained from patients with hepatocellular carcinoma who underwent radical surgical resection between June 2010 and December 2014 at Tianjin Medical University Cancer Institute and Hospital (Tianjin, China). Patients who had nonradical local treatments and systemic treatments were excluded from the study. The relationship between clinicopathologic characteristics and DNAJC24 expression in the 167 patients is summarized in Table S1. Pathologists examined all paraffin-embedded specimens using hematoxylin and eosin staining to confirm that tumor tissue contains more than 70% tumor cells and non-tumor tissue doesn’t contain tumor cells. All patients in this study provided written informed consent for sample collection and data analyses. The study was consistent with the ethical guidelines of the Helsinki Declaration and approved by the Ethics Committee.
Immunohistochemistry
Immunohistochemistry (IHC) staining for DNAJC24 was performed in 167 pairs of cancerous and matched adjacent nonmalignant tissue. IHC staining for CD31 was performed in the 166 cancerous tissues. The tissues were sequentially immersed in xylene and gradient ethanol to dewax and rehydration. Antigen retrieval was performed using citrate target retrieval solution. pH 6.0 (ZSGB-BIO, ZLI-9065) in a pressure cooker for 2.5 min then cooled naturally to room temperature. 3% hydrogen peroxide was used to inhibit endogenous hydrogen peroxidase activity. Subsequently, the samples were incubated with rabbit anti-DNAJC24(1:50, Abcam, ab246925) and rabbit anti-CD31(1:50, Abcam, ab28364) at room temperature for 30 min and overnight at 4 °C. After washed with phosphate-buffered saline (PBS), the samples were stained with secondary antibody for 1 h at room temperature. The cells were visualized with 3,3-diaminobenzidine solution (ZSGB-Bio, ZLI-9017) and counterstained with hematoxylin. The final IHC score of DNAJC24 was the product of the staining intensity score and percentage score. A final staining score ≥1 was defined as DNAJC24 high expression; the final staining score <1 was defined as DNAJC24 low expression. The staining intensity score of DNAJC24 was evaluated in four classes: 0, no immune response; 1, weak immune response; 2, medium strong immune response; 3, strong immune response. The staining percentage score of DNAJC24 was classified on a 4-point scale: 0, no positive cells; 1, <30% positive cells; 2, 30–60% positive cells; and 3, 60–100% positive cells. The density of CD31 < 30% was defined as CD31-Low, while ≥30% was defined as CD31-High.The sections were photographed using a light microscope (Olympus BX61).
Cell culture
PLC and HEK293T cells were purchased from American Type Culture Collection (ATCC; Manassas, VA, USA). Huh7 cells were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). The cell lines were cultivated in DMEM medium (Corning, NY, USA), supplemented with 1% penicillin/streptomycin (HyClone, Logan, UT, USA) and 10% fetal bovine serum (PAN-Seratech, Edenbach, Germany) under culture requirements (37 °C; 5% CO2).
Cell transfection
DNAJC24 shRNA was used to knockdown this gene. Packaging plasmids (VSVG and ΔR) and expression plasmids (OE and matched Ctrl; KD and matched Ctrl) were transfected into HEK293T cells using Lipofectamine 2000 (Invitrogen). After 48 h, the medium supernatant was collected to obtain lentiviral particles. PLC and Huh7 cells were infected with lentivirus to produce stable DNAJC24 knockdown (KD), DNAJC24 overexpression (OE) and matched control (Ctrl) cell lines. The sequences of DNAJC24 shRNA were listed in Table S2.
Western blotting and antibodies
Western blotting was conducted as described previously [17]. The following antibodies were used: anti-DNAJC24 (1:500) from Abcam, anti-β-actin (1:1000) from Santa Cruz Biotechnology, anti-LC3B (1:1000) from Cell Signaling Technology, anti- p62 (1:1000) from Santa Cruz Biotechnology, anti-HSF2 (1:500) from ABclonal, anti-CPS1(1:500) from ABclonal, anti-Caspase3 (1:1000) from Cell Signaling Technology, anti-Caspase9 (1:1000) from Cell Signaling Technology, goat anti-mouse IgG-HRP from Santa Cruz Biotechnology, and goat anti-rabbit IgG-HRP from Santa Cruz Biotechnology.
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from cells using TRIzol reagent (Ambion). cDNA was synthesized by RNA reverse transcription using the PrimeScript™ RT Master Mix kit (Takara, Japan). The amplification reaction was performed using the AceQ qPCR SYBR Green Master Mix kit according to the manufacturer’s instructions (Vazyme, China). Primer sequences are listed in Table S3.
Cell viability assays, colony formation assays, chemotaxis assays, invasion assays were performed as described previously [17]. According to the manufacturer’s instructions, cell proliferation assay was performed using the BeyoClick™ EdU-594 Cell Proliferation Kit (Beyotime Biotech. Inc.).
Immunofluorescence staining
Cells were seeded in twelve-well plates, fixed with 4% paraformaldehyde for 30 min at room temperature, washed with PBS and permeabilized with 0.2% Triton X-100 in PBS for 15 min. Cells were then blocked with 10% normal donkey serum for 60 min at room temperature. Subsequently, the cells were incubated overnight at 4 °C with rabbit anti-Ki67 (0.5 µg/ml, Abcam, ab15580). Then, the cells were incubated with Alexa-Fluor-conjugated secondary antibodies (Invitrogen) in 1% BSA for 1 h at room temperature. DAPI was used to counterstain the nuclei, and images were obtained by a fluorescence microscope (Invitrogen, EVOS M5000).
Dual-luciferase reporter assays
The transcriptional effect of HSF2 on DNAJC24 was assessed by dual-luciferase assay. The promoter region of DNAJC24 was amplified and the predicted binding sites -TTTTGGAACGTTT-was mutated to -GGGGTTCCATGGG-. Then, the wild type promoter and mutant type promoter of DNAJC24 were ligated into the luciferase reporter plasmid pPRO-RB-Report (RiboBio, China). The effect of HSF2 on DNAJC24 promoter activity was measured using a dual luciferase assay kit (Promega, E2920).
Protein synthesis assay
Global protein synthesis was assayed using a protein synthesis assay kit (Cayman Chemical,601100) according to the manufacturer’s instructions. Briefly, cells were seeded in 96-well plates and incubated for 30 min with o-propargyl-puromycin working solution in complete medium. Subsequently, cells were fixed with cell-based assay fixative, stained with 5 FAM-azide solutions, examined by a fluorescent plate reader (Bio-Tek Synergy H1) using a filter designed to detect FITC (excitation/emission = 485/535 nm) and photographed under a fluorescence microscope.
Assessment of intracellular ammonia
An ammonia assay kit (Abnova, KA0810) was used to detect intracellular ammonia according to the manufacturer’s instructions. Briefly, a total of 2 × 106 cells were washed with PBS and lysed in 100 µL assay buffer provided in the kit. A BCA protein assay kit (Thermo,23227) was used to assay the cell lysate protein concentration. Add 30 µg of cell lysate to 96 well plates, bring the volume to 50 µL/well with assay buffer. Add 50 µL of the Reaction Mix (42 µL Ammonia Assay Buffer, 2 µL Oxi red probe, 2 µL Enzyme Mix, 2 µL Developer, and 2 µL Converting Enzyme) to each well containing the test samples. Add 50 µL Sample Control Mix (44 µL Ammonia Assay Buffer, 2 µL Oxi red probe, 2 µL Enzyme Mix, and 2 µL Developer) to Sample Control. Mix well. The reaction was incubated for 1 h at 37 °C, protect from light. Optical density was measured at 570 nm using a microplate reader (BioTek Synergy H1).
Measurement of autophagic flux
Cells were transfected with the stubRFP-sensGFP-LC3 lentivirus purchased from GENE-CHEM following the manufacturer’s protocol. Then, cells were visualized using laser scanning confocal microscopy (LSM800, Zeiss). Autophagosomes were labeled yellow (mRFP and GFP) whereas autolysosomes were labeled red (mRFP only).
Bioinformatics analysis
We downloaded the raw data of HCC from TCGA (National Cancer Institute) official website. Then, the data were normalized by R Studio. We analyzed the expression of DNAJC24 and HSF2 using R Studio. The GEPIA (Gene Expression Profiling Interactive Analysis, cancer-pku.cn) online database or R Studio was used to analyze the correlation. Correlations between DNAJC24, HSF2 mRNA level and survival in patients with HCC were analyzed using the GEPIA online database. We used the online program JASPAR (http://jaspar.genereg.net/analysis) to search for potential transcription factors with binding sites in the DNAJC24 promoter.
Statistical analysis
Statistical analyses were performed using SPSS 25.0 or GraphPad Prism 8.0. All data are shown as the means ± SD. Differences between groups were evaluated by a two-tailed Student’s t test or one-way ANOVA. The univariate Kaplan–Meier method and multivariate Cox method were used to analyze the independent risk factors and survival curve of HCC patients. Statistical significance was defined as P < 0.05.
Results
DNAJC24 expression is elevated in HCC tissues and correlates with poor prognosis
Previously, our group found that cPLA2α [18, 19] and PNO1 [20] play a key role in the malignant progression of HCC. Interestingly, we examined the whole transcriptome of cells with different levels of cPLA2α and PNO1 and found that with the decrease of cPLA2α and PNO1, the expression of DNAJC24, a heat shock protein, also decreased (Fig. S1A, B). In addition, we found that DNAJC24 was positively correlated with cPLA2α and PNO1 at the mRNA level in HCC (Fig. S1C, D). These results made us interested in the role of DNAJC24 in HCC progression.To evaluate the role of DNAJC24 in the progression of HCC, we first analyzed that DNAJC24 mRNA expression was significantly upregulated in tumors compared with normal tissues based the TCGA Liver Hepatocellular Carcinoma dataset (n = 50) (Fig. 1A). Moreover, DNAJC24 mRNA expression was higher in tumors with more advanced stage (Fig. 1J). Data from the GEPIA online database showed that patients with high DNAJC24 mRNA expression had a worse prognosis, both in terms of disease-free survival and overall survival (OS) (Fig. 1B, C).
Fig. 1
DNAJC24 expression is generally upregulated in human HCC tissues and is associated with poor patient prognosis.
A Expression of DNAJC24 in cancer and paired normal liver tissues of 50 HCC patients based on data from the TCGA hepatocellular carcinoma dataset. B, C The Kaplan–Meier survival analysis of disease-free survival (B) and overall survival (C) of HCC patients analyzed by GEPIA (top 20%, high; bottom 80%, low). D Representative images of DNAJC24 in 167 HCC and paired para-tumor tissues stained with IHC (scale bar,200 μm or 100 μm). E IHC analysis of DNAJC24 expression in 167 pairs tissue of HCC specimens. F Positive rate of DNAJC24 in different tumor size subgroups (Group A, 25 cases; Group B, 114 cases; Group C 28 cases). G Percentage of high and low microvessel density in the DNAJC24 positive and negative subgroups. H, I The Kaplan–Meier survival analysis of recurrence-free survival (H) and overall survival (I) in 167 HCC patients. J Box plots of DNAJC24 expression in normal liver and tumor tissues (Clinical stages I to III) from the TCGA Database. *P < 0.05, ****P < 0.0001.
DNAJC24 expression is generally upregulated in human HCC tissues and is associated with poor patient prognosis.
A Expression of DNAJC24 in cancer and paired normal liver tissues of 50 HCC patients based on data from the TCGA hepatocellular carcinoma dataset. B, C The Kaplan–Meier survival analysis of disease-free survival (B) and overall survival (C) of HCC patients analyzed by GEPIA (top 20%, high; bottom 80%, low). D Representative images of DNAJC24 in 167 HCC and paired para-tumor tissues stained with IHC (scale bar,200 μm or 100 μm). E IHC analysis of DNAJC24 expression in 167 pairs tissue of HCC specimens. F Positive rate of DNAJC24 in different tumor size subgroups (Group A, 25 cases; Group B, 114 cases; Group C 28 cases). G Percentage of high and low microvessel density in the DNAJC24 positive and negative subgroups. H, I The Kaplan–Meier survival analysis of recurrence-free survival (H) and overall survival (I) in 167 HCC patients. J Box plots of DNAJC24 expression in normal liver and tumor tissues (Clinical stages I to III) from the TCGA Database. *P < 0.05, ****P < 0.0001.Next, we examined the protein expression of DNAJC24 in 167 paired HCC and non-tumor samples by IHC assays to further identify the effect of DNAJC24 on the prognosis of HCC (Fig. 1D). The relationship between clinicopathologic characteristics and DNAJC24 expression in the 167 patients is summarized in Table S1. The protein expression of DNAJC24 were also significantly higher in tumor than in corresponding non-tumor tissues (Fig. 1E). The positive rate of DNAJC24 increased with increasing tumor diameter (Fig. 1F). In HCC, tumor progression is associated with angiogenesis and microvascular density is associated with poor prognosis [21]. Therefore, we measured endothelial vessel density by anti-CD31 IHC. Interestingly, we found a higher density of CD31 in DNAJC24-positive tumors (Fig. 1G), suggesting that microvessel density in HCC was associated with DNAJC24 expression levels. We further explored the relationship between the protein expression of DNAJC24 and HCC patients’ survival. Based on DNAJC24 protein expression levels, patients were divided into the DNAJC24 high expression group (IHC staining positive, n = 99) and the low expression group (IHC staining negative, n = 68). Kaplan–Meier survival curves suggested that HCC patients with higher DNAJC24 protein expression had worse recurrence-free survival (RFS) and OS (Fig. 1H, I). There are gender differences in the incidence and prognosis of HCC [22-24]. Therefore, we did survival analysis after grouping 167 patients by gender. The results for the male group were consistent with the total population (Fig. S2A, C), and there was a trend for the female group to be consistent with the total population (Fig. S2B, D). The Cox regression model showed that increased DNAJC24 expression was an independent risk factor for the OS and RFS of HCC patients (Table 1). Then, we compared the accuracy of predictive survival probability by two nomogram models (with or without DNAJC24 staining score) using the C-index (Fig. S3). The C-index of the model with the DNAJC24 staining score was higher than that without the DNAJC24 staining score (0.661 vs. 0.636), suggesting that adding DNAJC24 staining score into the nomogram model increases the predictive value (Fig. S3). Taken together, by using IHC staining of a large number of HCC tissues and online database, we found that DNAJC24 expression was elevated in HCC tissues and was an independent risk factor for HCC prognosis, while DNAJC24 expression levels correlated with tumor size and microvessel density.
Table 1
Univariate and multivariate analysis of prognostic factors associated with OS and DFS in 167 HCC patients.
HCC patients (n = 167)
Number
Univariate analysis
Multivariate analysis
Univariate analysis
Multivariate analysis
5-year OS (%)
P value
HR (95% CI)
P value
5-year DFS (%)
P value
HR (95% CI)
P value
Age(years): ≥55/<55
92/75
38.6/42.0
0.742
18.0/17.5
0.895
Sex: male/female
137/30
41.5/28.4
0.097
18.8/15.0
0.201
HBV: Yes/No
131/36
36.9/53.2
0.226
17.0/34.2
0.224
Liver cirrhosis: Yes/No
90/77
41.5/38.6
0.741
17.0/18.9
0.322
Tumor size(cm): ≥3/<3
142/25
38.6/49.4
0.12
15.7/37.4
0.055
Mavi: Yes/No
15/152
14.9/42.1
0.008
1.128 (0.482, 2.623)
0.780
4.9/19.7
0.000
2.062 (0.904, 4.703)
0.085
Mivi: Yes/No
93/74
29.3/49.4
0.025
1.495 (1.000, 2.235)
0.050
12.0/21.2
0.101
AFP(ng/ml): ≥20/<20
86/81
29.0/51.5
0.004
1.308 (0.933, 1.832)
0.004
11.9/26.0
0.002
1.000 (1.000, 1.000)
0.0001
BCLC stage: 0&A/B&C
141/26
46.7/15.9
0.001
1.963 (1.007, 3.825)
0.048
19.8/6.538
0.000
1.535 (0.794, 2.965)
0.202
Staining score of DNAJC24: ≥1/<1
99/68
36.5/54.2
0.011
2.048 (1.352, 3.101)
0.001
16.8/26.4
0.028
1.643 (1.129, 2.391)
0.009
Bold is used to emphasize that the value is statistically significant.
AFP α-fetoprotein, BCLC Barcelona Clinic Liver Cancer, HBV, hepatitis B virus, Mavi macrovascular invasion, Mivi microvascular invasion.
Univariate and multivariate analysis of prognostic factors associated with OS and DFS in 167 HCC patients.Bold is used to emphasize that the value is statistically significant.AFP α-fetoprotein, BCLC Barcelona Clinic Liver Cancer, HBV, hepatitis B virus, Mavi macrovascular invasion, Mivi microvascular invasion.
DNAJC24 promotes the proliferation and motility of HCC cells
Then, we investigated the biological functions of DNAJC24 in HCC cells. Full-length human DNAJC24 was cloned into a lentiviral vector and then stably transfected into the PLC and Huh7 human HCC cell lines. The overexpression efficiency of DNAJC24 was confirmed by qRT-PCR and Western blotting (Fig. 2A–D). DNAJC24 overexpression resulted in a considerable promotion effect on the proliferation of HCC cells as evidenced by the CCK-8 cell viability assay (Fig. 2E, G). EdU staining assays also confirmed that ectopic overexpression of DNAJC24 promoted the proliferation of HCC cells (Figs. 2F, H). In vitro chemotaxis and Matrigel invasion assays indicated that DNAJC24 overexpression efficiently increased the motility of PLC (Fig. 2I, J) and Huh7 (Fig. 2K, L) cells. In summary, we verified that overexpression of DNAJC24 can promote the proliferation and motility of HCC cells, which in turn could lead to poor prognosis of HCC patients.
Fig. 2
DNAJC24 promotes proliferation and motility of HCC cells in vitro.
A, C PLC and Huh7 cells were infected with a lentivirus to produce stable DNAJC24 overexpression (OE) cells. qRT-PCR was performed to determine levels of DNAJC24 mRNA. β-actin was used as an internal control. B, D Western blotting was performed to determine levels of DNAJC24 protein. E, G CCK-8 cell viability assay analysis of the impact of DNAJC24 ectopic overexpression on PLC (E) and Huh7 (G) cell growth. Results were normalized to viability at day 0 and represented as fold change. F, H The effect of ectopic overexpression of DNAJC24 on the proliferation of PLC (F) and Huh7 (H) cells was analyzed by EdU staining. Representative images and EdU positive cell rates are as shown. I–L Chemotaxis (I, K) and Matrigel invasion (J, L) assays were used to detect the effect of ectopic overexpression of DNAJC24 on PLC (I, J) and Huh7 (K, L) motility. Data were presented as mean ± SEM. n = 2–5. **P < 0.01, ***P < 0.001, ****P < 0.0001.
DNAJC24 promotes proliferation and motility of HCC cells in vitro.
A, C PLC and Huh7 cells were infected with a lentivirus to produce stable DNAJC24 overexpression (OE) cells. qRT-PCR was performed to determine levels of DNAJC24 mRNA. β-actin was used as an internal control. B, D Western blotting was performed to determine levels of DNAJC24 protein. E, G CCK-8 cell viability assay analysis of the impact of DNAJC24 ectopic overexpression on PLC (E) and Huh7 (G) cell growth. Results were normalized to viability at day 0 and represented as fold change. F, H The effect of ectopic overexpression of DNAJC24 on the proliferation of PLC (F) and Huh7 (H) cells was analyzed by EdU staining. Representative images and EdU positive cell rates are as shown. I–L Chemotaxis (I, K) and Matrigel invasion (J, L) assays were used to detect the effect of ectopic overexpression of DNAJC24 on PLC (I, J) and Huh7 (K, L) motility. Data were presented as mean ± SEM. n = 2–5. **P < 0.01, ***P < 0.001, ****P < 0.0001.
Under stress, heat shock factors 2 upregulates DNAJC24 expression in HCC cells
HSPs are essential components of a cell’s defense mechanism against stress injuries [25]. Of all human HSP families, the DNAJ/HSP40 family has the largest number of members. All of the DNAJ/HSP40s contain a J domain through which they bind to Hsp70s and can be categorized into three subfamilies (DNAJA, DNAJB, DNAJC) [26]. DNAJC24 belongs to type III DNAJ/HSP40s which have only one J domain. Since HSPs are usually responsive to environmental stress, we wanted to explore whether DNAJC24 is responsive to external stressful stimuli. We artificially upregulated the ambient temperature of PLC and Huh7 cells, and then detected changes in DNAJC24 expression by Western blotting and qRT-PCR. As expected, as the ambient temperature increased, the expression of DNAJC24 was upregulated and showed a certain degree of stimulus intensity dependence (Figs. 3C and S4C). In addition, we changed the medium to PBS to simulate starvation stimulation or added CoCl2 (200 μM) to the medium to simulate hypoxia. Interestingly, HCC cells upregulated DNAJC24 expression after stimulation by starvation and hypoxia and the extent of DNAJC24 upregulation showed some time dependence (Figs. 3A, B and S4A, B). These results showed that the expression of DNAJC24 in HCC cells increased after being stimulated by the external stressful stimuli.
Fig. 3
External stimuli such as starvation, hypoxia and heat upregulate DNAJC24 expression through HSF2 in HCC cells.
A The cell culture medium of PLC and Huh7 was changed to PBS and the cells were cultured in PBS for 0h, 3h and 6h respectively and then the cells were lysed. Western blotting was performed to determine levels of DNAJC24 protein. B Adding CoCl2 (final concentration 200 μM) to the medium of PLC and Huh7 cells to simulate hypoxic environment, and the cells were incubated in it for 0h, 4h, 6h, 8h respectively and then lysed. Western blotting was performed to determine levels of DNAJC24 protein. C PLC and Huh7 cells were cultured at 37 °C, 39 °C, 41 °C, 43 °C respectively in 5% CO2 for 3h, and then the cells were lysed. Western blotting was performed to determine levels of DNAJC24 protein. D–F Analysis of the possible correlation between DNAJC24 and HSF1 (D), HSF2 (E), HSF4 (F) mRNA levels based on the data from the TCGA HCC dataset. Data were analyzed using Spearman’s rank correlation coefficient. G Box plots of HSF2 expression in cancer and paired normal liver tissues of HCC patients based on data from the TCGA HCC dataset. H Box plots of HSF2 expression in normal liver and tumor tissues (Clinical stages I–III) based on data from the TCGA HCC database. I The Kaplan–Meier survival analysis of overall survival of HCC patients analyzed by GEPIA (top 50%, high; bottom 50%, low). J Lysis of PLC and Huh7 cells after applying starvation, hypoxia, and heat (40 °C) stimulation to 3h. Western blotting was performed to determine levels of HSF2 protein. K Stable cell lines with HSF2 overexpression were constructed using lentiviral transfection in PLC and Huh7 cells, and the protein levels of HSF2 and DNAJC24 were detected by Western blotting after cell lysed. L DNAJC24 wild-type promoter (pPRO-RB-promoterWT) and mutant promoter (pPRO-RB-promoterMUT)were ligated to the reporter vector. A dual luciferase assay was performed to assess the effects of HSF2 overexpression on DNAJC24 transcription in PLC cells. Data were presented as mean ± SEM. n = 3. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
External stimuli such as starvation, hypoxia and heat upregulate DNAJC24 expression through HSF2 in HCC cells.
A The cell culture medium of PLC and Huh7 was changed to PBS and the cells were cultured in PBS for 0h, 3h and 6h respectively and then the cells were lysed. Western blotting was performed to determine levels of DNAJC24 protein. B Adding CoCl2 (final concentration 200 μM) to the medium of PLC and Huh7 cells to simulate hypoxic environment, and the cells were incubated in it for 0h, 4h, 6h, 8h respectively and then lysed. Western blotting was performed to determine levels of DNAJC24 protein. C PLC and Huh7 cells were cultured at 37 °C, 39 °C, 41 °C, 43 °C respectively in 5% CO2 for 3h, and then the cells were lysed. Western blotting was performed to determine levels of DNAJC24 protein. D–F Analysis of the possible correlation between DNAJC24 and HSF1 (D), HSF2 (E), HSF4 (F) mRNA levels based on the data from the TCGA HCC dataset. Data were analyzed using Spearman’s rank correlation coefficient. G Box plots of HSF2 expression in cancer and paired normal liver tissues of HCC patients based on data from the TCGA HCC dataset. H Box plots of HSF2 expression in normal liver and tumor tissues (Clinical stages I–III) based on data from the TCGA HCC database. I The Kaplan–Meier survival analysis of overall survival of HCC patients analyzed by GEPIA (top 50%, high; bottom 50%, low). J Lysis of PLC and Huh7 cells after applying starvation, hypoxia, and heat (40 °C) stimulation to 3h. Western blotting was performed to determine levels of HSF2 protein. K Stable cell lines with HSF2 overexpression were constructed using lentiviral transfection in PLC and Huh7 cells, and the protein levels of HSF2 and DNAJC24 were detected by Western blotting after cell lysed. L DNAJC24 wild-type promoter (pPRO-RB-promoterWT) and mutant promoter (pPRO-RB-promoterMUT)were ligated to the reporter vector. A dual luciferase assay was performed to assess the effects of HSF2 overexpression on DNAJC24 transcription in PLC cells. Data were presented as mean ± SEM. n = 3. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.The HSFs (heat shock transcription factors) were direct transcriptional factors of some genes encoding HSPs [27]. However, whether HSFs can regulate DNAJC24 expression or which member regulates DNAJC24 expression hasn’t been reported. Among vertebrates, HSF 1, 2, and 4 are ubiquitous, whereas HSF3 has been characterized only in avian species [28]. The correlation analysis using TCGA database showed that DNAJC24 expression was highly positively correlated with HSF2 expression (Fig. 3E), but weakly correlated with HSF1 (Fig. 3D) and HSF4 (Fig. 3F). HSF2 expression was also higher in HCC tissues than in para-cancerous tissues (Fig. 3G), and the HSF2 expression level increased with tumor stage (Fig. 3H). These are consistent with the expression of DNAJC24 in HCC tissues. As above, we detected changes in HSF2 expression in HCC cells after being stimulated by starvation, hypoxia, and heat. Similarly, HSF2 expression levels were upregulated with the administration of these stress stimuli (Fig. 3J). More importantly, as with DNAJC24, OS was shorter in patients with high HSF2 expression (Fig. 3I). In addition, we constructed HSF2 overexpression cell lines in PLC and Huh7 cells (Figs. S5A, B and 3K) and found that DNAJC24 expression was upregulated in HSF2-OE cells (Figs. S5C, D and 3K).Next, we searched the JASPAR website and found that HSF2 may bind to a segment of the DNAJC24 promoter sequence (5’-TTTTGGAACGTTT-3’), thereby regulating DNJAC24 expression (Fig. S5E). We amplified the core promoter region of DNAJC24 and mutated 5’-TTTTGGAACGTTT-3’ to 5’-GGGGTTCCATGGG-3’. Then, the wild type promoter and mutant type promoter of DNAJC24 were ligated into pPRO-RB-Report. Subsequent dual-luciferase reporting experiments shown that HSF2 could transcriptionally regulate DNJC24 expression, and mutating the predicted binding site could inhibit HSF2 transcriptional regulation of DNAJC24 (Fig. 3L). These data suggest that HSF2 is a transcriptional regulator of DNAJC24.
Knockdown of DNAJC24 inhibits proliferation, motility, and protein synthesis in HCC cells
The above results suggest that environmental stress can upregulate DNAJC24 expression through HSF2, and upregulated DNAJC24 can promote the proliferation and motility of HCC cells, which in turn leads to poor prognosis of HCC patients. Does targeting DNAJC24 improve the poor prognosis of HCC patients? To answer this question, we constructed cell lines with stable down-expression of DNAJC24 in PLC and Huh7 cells by using the lentiviral vector carrying DNAJC24 shRNA. The efficiency of DNAJC24 knockdown was confirmed by qRT-PCR and Western blotting (Fig. 4A–D). DNAJC24 knockdown resulted in a considerable inhibitory effect on the proliferation (Fig. 4E, H) and colony-forming ability (Fig. 4F, I) of HCC cells. We found that the positive rate of Ki67 (a marker of cell proliferation [29]) was lower in DNAJC24-KD cells (Fig. 4G, J). This also supports that down-regulation of DNAJC24 can inhibit the proliferation of HCC cells. Migration and invasion assays verified that the down-regulation of DNAJC24 expression suppressed the migration and invasion abilities of PLC and Huh7 cells, respectively (Fig. 4K, L, N, O).
Fig. 4
Knockdown of DNAJC24 inhibits proliferation, motility, and protein synthesis in HCC cells in vitro.
A, C PLC and Huh7 cells were infected with a lentivirus to produce stable DNAJC24 knockdown (KD) cells. qRT-PCR was performed to determine levels of DNAJC24 mRNA. β-actin was used as an internal control. B, D Western blotting was performed to determine levels of DNAJC24 protein. E, H CCK-8 cell viability assay analysis of the impact of DNAJC24 knockdown on PLC (E) and Huh7 (H) cell growth. Results were normalized to viability at day 0 and represented as fold change. F, I Colony formation assay showing the effects of DNAJC24 knockdown on PLC (F) and Huh7 (I) cell growth. G, J Immunofluorescence staining detected Ki67 expression in DNAJC24-KD cells and control cells. Representative images and Ki67 positive cell rates are as shown. K, L, N, O Chemotaxis (K, N) and Matrigel invasion (L, O) assays were used to detect the effect of DNAJC24 knockdown on PLC (K, L) and Huh7 (N, O) motility. M, P Newly synthesized protein was detected in PLC (M) and Huh7 (P) cells after DNAJC24 knockdown using a protein synthesis assay kit. Data were presented as mean ± SEM. n = 2–3. *P < 0.05, **P < 0.01.
Knockdown of DNAJC24 inhibits proliferation, motility, and protein synthesis in HCC cells in vitro.
A, C PLC and Huh7 cells were infected with a lentivirus to produce stable DNAJC24 knockdown (KD) cells. qRT-PCR was performed to determine levels of DNAJC24 mRNA. β-actin was used as an internal control. B, D Western blotting was performed to determine levels of DNAJC24 protein. E, H CCK-8 cell viability assay analysis of the impact of DNAJC24 knockdown on PLC (E) and Huh7 (H) cell growth. Results were normalized to viability at day 0 and represented as fold change. F, I Colony formation assay showing the effects of DNAJC24 knockdown on PLC (F) and Huh7 (I) cell growth. G, J Immunofluorescence staining detected Ki67 expression in DNAJC24-KD cells and control cells. Representative images and Ki67 positive cell rates are as shown. K, L, N, O Chemotaxis (K, N) and Matrigel invasion (L, O) assays were used to detect the effect of DNAJC24 knockdown on PLC (K, L) and Huh7 (N, O) motility. M, P Newly synthesized protein was detected in PLC (M) and Huh7 (P) cells after DNAJC24 knockdown using a protein synthesis assay kit. Data were presented as mean ± SEM. n = 2–3. *P < 0.05, **P < 0.01.DNAJC24, also known as DPH4, is a homolog of the S. cerevisiae diphthamide methyltransferase proteins (DPHs). These enzymes are involved in the synthesis of diphthamide, and previous studies have shown that disrupting the expression of DPHs reduces protein synthesis [30, 31]. Therefore, we examined the effect of knocking down DNAJC24 on global protein synthesis and found that DNAJC24 knockdown could also inhibit protein synthesis (Fig. 4M, P). All these results suggest that DNAJC24 may be a potential therapeutic target for HCC.
Knocking down DNAJC24 disrupts autophagic flow
Although the positive rate of Ki67 decreased in DNAJC24-KD cells, flow cytometric analysis of cell cycle revealed no increase in cells in G0 + G1 phase and no statistically significant differences in other phases (Fig. S6A), suggesting that DNAJC24 didn’t affect proliferation primarily by influencing the cell cycle. In addition, there was no significant effect of DNAJC24 knockdown on apoptosis by flow cytometric (Fig. S6B). The detection of apoptosis markers caspas3, caspase9 and their cleaved forms also didn’t reveal an increase in apoptosis in DNAJC24-KD cells (Fig. S6C, D). However, we did observe reduced growth in cells with DNAJC24 knockdown. Autophagy is an evolutionarily conserved process. It may promote the survival of tumor cells under the metabolic stress [32], but overactivated autophagy leads to another type of cell death [33]. Therefore, we investigated whether the reduction in cell growth induced by DNAJC24 knockdown is due to autophagy.First, we examined the changes of autophagy marker LC3B in DNAJC24-KD cells. LC3B-II was increased in DNAJC24-KD HCC cells (Fig. 5A, B left). Second, we detected changes in p62, which is a substrate for autophagy [34]. Surprisingly, we did observe a modest accumulation of p62 in DNAJC24-KD cells (Fig. 5C left and D left). In general, increased intracellular LC3B-II represents enhanced autophagy, and p62 should be reduced due to increased degradation. However, we observed a simultaneous increase in intracellular LC3B and p62. Considering that autophagy is a dynamic process including autophagic flux from of autophagosome to lysosome [34]. Thus the observed phenomenon may be caused by blocked fusion of autophagosome and lysosome or disrupted lysosome function, as previously reported [35, 36]. Next, we performed the experiments in the presence of the lysosomal pump inhibitor Bafilomycin A1(Baf-A1), which allows one to infer the rate of LC3-II neosynthesis [34, 35]. Interestingly, in the presence of Baf-A1, knocking down DNAJC24 didn’t result in the accumulation of LC3B-II (Fig. 5A right and B right), nor did p62 (Fig. 5C right and D right) change significantly in DNAJC24-KD cells, suggesting that DNAJC24 knockdown didn’t affect the initiation of autophagy. These experimental results all suggest that DNAJC24 knockdown affects the autophagolysosome phase of the autophagic flux.
Fig. 5
Knocking down DNAJC24 disrupts autophagic flow.
A, B, C, D DNAJC24-KD cells and control cells were cultured under normal conditions or in medium supplemented with Bafilomycin A1 (final concentration 400 nM) for 24h. Western blotting was performed to determine protein levels of LC3B (A, B) and p62 (C, D) in cell lysates. C PLC DNAJC24-KD cells and control cells transfected with GFP-mRFP-LC3 lentivirus and analyzed by confocal microscopy. Quantification of the number of fluorescent puncta exhibiting green (GFP), red (mRFP) or red-only fluorescence (obtained by subtracting green puncta to the total red puncta) is shown (right graphs). Pictures at higher magnification are shown. Bars, 10 μm. Data were presented as mean ± SEM. n = 3. *P < 0.05.
Knocking down DNAJC24 disrupts autophagic flow.
A, B, C, D DNAJC24-KD cells and control cells were cultured under normal conditions or in medium supplemented with Bafilomycin A1 (final concentration 400 nM) for 24h. Western blotting was performed to determine protein levels of LC3B (A, B) and p62 (C, D) in cell lysates. C PLC DNAJC24-KD cells and control cells transfected with GFP-mRFP-LC3 lentivirus and analyzed by confocal microscopy. Quantification of the number of fluorescent puncta exhibiting green (GFP), red (mRFP) or red-only fluorescence (obtained by subtracting green puncta to the total red puncta) is shown (right graphs). Pictures at higher magnification are shown. Bars, 10 μm. Data were presented as mean ± SEM. n = 3. *P < 0.05.To better assess the autophagic flux, PLCDNAJC24-KD and control cells were transfected with the stubRFP-sensGFP-LC3 lentivirus, which allows us to discriminate between early autophagosomes from acidified autophagolysosomes [37]. Consistent with the results obtained from Western blotting, we observed an increased number of mRFP-positive puncta and larger LC3 dots in DNAJC24-KD cells, suggesting more LC3 accumulation in DNAJC24-KD cells. Strikingly, by quantifying the number of red-only puncta (autophagolysosomes), we found that it was higher in control cells than in DNAJC24-KD cells (Fig. 5E). Thus, in DNAJC24-KD cells, the number of autophagosomes increased, and this increase wasn’t reflected in an equivalent increase in their maturation. In summary, we demonstrated that down-regulated expression of DNAJC24 interfered with the degradation of autophagosomes leading to the accumulation of LC3B and p62.In addition, LC3B-II was increased and p62 was decreased in DNAJC24-OE HCC cells (Fig. S7A). This suggests that DNAJC24 overexpression enhanced autophagy in HCC cells. In the presence of Baf-A1, DNAJC24 overexpression resulted in a significant accumulation of LC3B-II and p62 (Fig. S7B), indicating that overexpression of DNAJC24 did promote the initiation of autophagy. Early-stage autophagy inhibitor 3-methyladenine (3MA) and late-stage autophagy inhibitor Baf-A1 could significantly inhibit the proliferation of PLC-DNAJC24-OE cells (Fig. S7C). These data suggest that autophagic flux increases when DNAJC24 is overexpressed and that blocking autophagy reduces the proliferation of DNAJC24-OE HCC cells.
DNAJC24 knockdown inhibits HCC cells autophagy and proliferation by affecting the metabolism of ammonia
To further investigate how knocking down DNAJC24 affects the proliferation and autophagy of HCC cells, we performed whole-transcriptome sequencing on PLCDNAJC24-KD cells and control cells (Fig. S8A). As shown in the volcano plot, 323 genes were upregulated, and 183 genes were downregulated after DNAJC24 knockdown with the threshold of a P < 0.05 and a | log2 FC | > 0.0 (Fig. S8B). Based on the RNA-seq results, we applied the interactions in the STRING protein interaction database for the analysis of DEGs interaction networks. We identified two proteins with potentially relevant roles for DNAJC24: CPS1(Carbamoyl-phosphate synthase 1) and CAD (Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase) (Fig. 6A). Many metabolism-related pathways were enriched, such as cholesterol metabolism, amino acid metabolism, fatty acid metabolism by pathway enrichment analysis based on the DEGs (Fig. 6B, C). Notably, GO analysis suggested that DNAJC24 affected the urea metabolic process (Fig. 6B). In addition to pathways in cancer, KEGG pathway enrichment analysis showed that genes in the arginine biosynthesis and alanine, aspartate, glutamate metabolism pathways were enriched (Fig. 6C). CPS1 catalyzes the rate-limiting step of the urea cycle. Arginine, alanine, aspartate and glutamate are also closely associated with the urea cycle. This suggests that DNAJC24 knockdown affects the urea cycle. The further results showed that CPS1 expression was decreased in DNAJC24-KD cells (Fig. 6D). CPS1 initiates nitrogen disposal by catalyzing the production of carbamoyl phosphate (CP) from ammonia and bicarbonate in mitochondria. DNAJC24 knockdown resulted in intracellular ammonia accumulation (Fig. 6E, F). It has been reported that intracellular ammonia accumulation affects autophagy [38, 39] and proliferation [40]. Next, we examined the effect of ammonia on autophagy in PLC and Huh7 cells. NH4Cl (25 mM) significantly led to intracellular LC3B accumulation (Fig. 6G left and H left). We also observed that the addition of Baf-A1 caused this difference to disappear (Fig. 6G right and H right). The effect of NH4Cl on autophagy was identical to the effect of DNAJC24 knockdown on autophagy, suggesting that knocking down DNAJC24 affects autophagy by elevating intracellular ammonia. Finally, we assayed the effect of ammonia on the proliferation of PLC and Huh7 cells. CCK-8 cell viability assay confirmed that NH4Cl (25 mM) significantly inhibited the proliferation of PLC and Huh7 cells (Fig. 6I, J). In summary, our findings demonstrated that extracellular stress could upregulate DNAJC24 expression through transcriptional regulation of HSF2 and targeting DNAJC24 can affect the autophagy and proliferation of HCC cells by interfering with ammonia metabolism, thereby inhibiting the malignant development of HCC (Fig. 7).
Fig. 6
DNAJC24 knockdown inhibits HCC cells proliferation and autophagy by affecting the metabolism of ammonia.
A Interactions in the STRING protein interaction database were used to analyze DEGs interaction networks. B, C GO functional enrichment analysis (B) and KEGG pathway enrichment analysis (C) of DEGs was performed to identify functionally related gene pathways. D Western blotting was performed to determine protein levels of CPS1. E, F NH4+/NH3 levels were measured in the PLC-KD (E) cells or Huh7-KD (F) cells as well as in the corresponding control cells using an ammonia assay kit by spectrophotometric analysis at 570 nm with extrapolation from the standard curve and expressed in nmol/mg protein. G, H NH4Cl (final concentration 25 mM) or/and Bafilomycin A1 (final concentration 400 nM) was added to the culture medium of PLC or Huh7 and incubated for 24h, respectively. Western blotting was performed to determine protein levels of LC3B. I, J CCK-8 cell viability assay analysis of the impact of NH4Cl (final concentration 25 mM) on PLC (I) and Huh7 (J) cell growth. Results were normalized to viability at day 0 and represented as fold change. Data were presented as mean ± SEM. n = 3–5. **P < 0.01, ****P < 0.0001.
Fig. 7
Schematic model of research conclusions.
Extracellular stress could upregulate DNAJC24 expression through transcriptional regulation of HSF2 and targeting DNAJC24 can affect the autophagy and proliferation of HCC cells by decreasing the expression of CPS1, the first key enzyme of the urea cycle.
DNAJC24 knockdown inhibits HCC cells proliferation and autophagy by affecting the metabolism of ammonia.
A Interactions in the STRING protein interaction database were used to analyze DEGs interaction networks. B, C GO functional enrichment analysis (B) and KEGG pathway enrichment analysis (C) of DEGs was performed to identify functionally related gene pathways. D Western blotting was performed to determine protein levels of CPS1. E, F NH4+/NH3 levels were measured in the PLC-KD (E) cells or Huh7-KD (F) cells as well as in the corresponding control cells using an ammonia assay kit by spectrophotometric analysis at 570 nm with extrapolation from the standard curve and expressed in nmol/mg protein. G, H NH4Cl (final concentration 25 mM) or/and Bafilomycin A1 (final concentration 400 nM) was added to the culture medium of PLC or Huh7 and incubated for 24h, respectively. Western blotting was performed to determine protein levels of LC3B. I, J CCK-8 cell viability assay analysis of the impact of NH4Cl (final concentration 25 mM) on PLC (I) and Huh7 (J) cell growth. Results were normalized to viability at day 0 and represented as fold change. Data were presented as mean ± SEM. n = 3–5. **P < 0.01, ****P < 0.0001.
Schematic model of research conclusions.
Extracellular stress could upregulate DNAJC24 expression through transcriptional regulation of HSF2 and targeting DNAJC24 can affect the autophagy and proliferation of HCC cells by decreasing the expression of CPS1, the first key enzyme of the urea cycle.
Discussion
The key findings of this report are as follows. First, extracellular stress can upregulate DNAJC24 expression through transcriptional regulation of HSF2, and high expression of DNAJC24 can promote proliferation and motility of HCC cells, leading to poor prognosis of HCC patients; second, we confirmed that targeting DNAJC24 can affect the proliferation and autophagy of HCC cells by interfering with ammonia metabolism, thereby inhibiting the malignant development of HCC.HSPs are a large family of chaperones that are involved in protein folding and maturation of a variety of “client” proteins protecting them from degradation, oxidative stress, hypoxia, and thermal stress [41]. DNAJ/HSP40 is a large and diverse family with more than 40 different members. DNAJ/HSP40 family members have been documented to influence tumor progression by participating in the stress response [42, 43]. In contrast, whether DNAJC24 is involved in the stress response and its role in tumors hasn’t been studied. In this study we demonstrated that extracellular stress could upregulate DNAJC24 expression through transcriptional regulation of HSF2 and that high expression of DNAJC24 promotes proliferation and motility of HCC cells, leading to poor prognosis of HCC patients. By immunohistochemistry staining of 167 HCC tissues, we found that the expression of DNAJC24 correlated with tumor size and vessel density. As tumor size increases, there are various stresses within the tumor, and increased vascular density is a coping strategy for hypoxia [44] and nutrient deficiency [45, 46]. DNAJC24 may bridge the gap between tumor size and vascular density.HSFs were originally described to recognize a consensus heat shock element (HSE) DNA binding site and activate genes encoding protein chaperones in response to elevated temperatures [27]. Whether HSFs can regulate DNAJC24 expression or which member regulates DNAJC24 expression has not been reported. In our study, we found that HSF2 was highly correlated with DNAJC24, but not HSF1. Data from TCGA database also confirm that HSF2 shares the same expression pattern as DNAJC24 in HCC, such as higher expression in cancerous tissues and higher expression in advanced HCC. Moreover, the expression levels of both HSF2 and DNAJC24 are increased by the application of external stimuli. Most importantly, high expression of HSF2 is also associated with poor prognosis in HCC patients. We eventually confirmed that HSF2 can regulate DNAJC24 expression by a dual-luciferase reporter assay. HSF1 can promote cancer initiation and progression, which has been proven by numerous studies [27, 47]. Compared to HSF1, the role of HSF2 in malignancy is inconclusive. J K Björk et al. demonstrated that HSF2 is a suppressor of prostate cancer invasion [48], but another study demonstrated that HSF2 was increased in lung cancer and associated with the occurrence of lung cancer by enhancing the expression of HSPs [49]. However, our study showed that HSF2 is a cancer-promoting gene in HCC. We also note that activation of HSF1 is a multistep and highly regulated process. Under normal conditions, mammalian HSF1 exists mainly in an inactive form. In response to various stresses HSF1 is converted to an active form with DNA binding capacity [50]. Thus, the transcriptional regulatory effect of HSF1 on target genes is dependent on activity changes rather than expression. Therefore, the absence of correlation between HSF1 and DNAJC24 doesn’t deny that HSF1 may transcriptionally regulate the expression of DNAJC24. Whether HSF1 can regulate DNAJC24 needs to be further investigated.Under normal culture conditions, DNAJC24 knockdown affected neither the cell cycle nor apoptosis of HCC cells but did affect autophagy. Autophagy is a highly regulated catabolic process, involved in the turnover of damaged organelles and cytoplasmic material to fuel starving cells and to maintain cellular homeostasis during either normal or stress conditions [51]. Therefore, autophagy is also a strategy for cells to cope with stress. In this respect, knocking down DNAJC24 did affect the cellular response to stress. RNA-seq revealed that DNAJC24 knockdown affected CPS1 and thus ammonia metabolism. CPS1 is a mitochondrial enzyme that catalyzes the first committed step of the urea cycle, which is important for the removal of excess ammonia from the cells. It has been demonstrated that reduced CPS1 expression leads to intracellular ammonia accumulation [40, 52]. Le Li et al. demonstrated that reduced CPS1 expression leads to intracellular ammonia accumulation and thus inhibits cell proliferation [40]. Our study confirmed for the first time that DNAJC24 can affect autophagy in hepatocellular carcinoma by interfering with ammonia metabolism.Supplementary Fig 1Supplementary Fig 2Supplementary Fig 3Supplementary Fig 4Supplementary Fig 5supplementary Figure 6supplementary Figure 7supplementary Figure 8Supplementary Figure LegendsSupplementary Table 1Supplementary Table 2Supplementary Table 3authorship contribution statementreproducibility checklistFull length western blotsOriginal Data File
Authors: Danielle E Jondal; Scott M Thompson; Kim A Butters; Bruce E Knudsen; Jill L Anderson; Rickey E Carter; Lewis R Roberts; Matthew R Callstrom; David A Woodrum Journal: Radiology Date: 2018-05-08 Impact factor: 11.105
Authors: Daniel J Klionsky; Kotb Abdelmohsen; Akihisa Abe; Md Joynal Abedin; Hagai Abeliovich; Abraham Acevedo Arozena; Hiroaki Adachi; Christopher M Adams; Peter D Adams; Khosrow Adeli; Peter J Adhihetty; Sharon G Adler; Galila Agam; Rajesh Agarwal; Manish K Aghi; Maria Agnello; Patrizia Agostinis; Patricia V Aguilar; Julio Aguirre-Ghiso; Edoardo M Airoldi; Slimane Ait-Si-Ali; Takahiko Akematsu; Emmanuel T Akporiaye; Mohamed Al-Rubeai; Guillermo M Albaiceta; Chris Albanese; Diego Albani; Matthew L Albert; Jesus Aldudo; Hana Algül; Mehrdad Alirezaei; Iraide Alloza; Alexandru Almasan; Maylin Almonte-Beceril; Emad S Alnemri; Covadonga Alonso; Nihal Altan-Bonnet; Dario C Altieri; Silvia Alvarez; Lydia Alvarez-Erviti; Sandro Alves; Giuseppina Amadoro; Atsuo Amano; Consuelo Amantini; Santiago Ambrosio; Ivano Amelio; Amal O Amer; Mohamed Amessou; Angelika Amon; Zhenyi An; Frank A Anania; Stig U Andersen; Usha P Andley; Catherine K Andreadi; Nathalie Andrieu-Abadie; Alberto Anel; David K Ann; Shailendra Anoopkumar-Dukie; Manuela Antonioli; Hiroshi Aoki; Nadezda Apostolova; Saveria Aquila; Katia Aquilano; Koichi Araki; Eli Arama; Agustin Aranda; Jun Araya; Alexandre Arcaro; Esperanza Arias; Hirokazu Arimoto; Aileen R Ariosa; Jane L Armstrong; Thierry Arnould; Ivica Arsov; Katsuhiko Asanuma; Valerie Askanas; Eric Asselin; Ryuichiro Atarashi; Sally S Atherton; Julie D Atkin; Laura D Attardi; Patrick Auberger; Georg Auburger; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Maria Laura Avantaggiati; Limor Avrahami; Suresh Awale; Neelam Azad; Tiziana Bachetti; Jonathan M Backer; Dong-Hun Bae; Jae-Sung Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Seung-Hoon Baek; Stephen Baghdiguian; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xue-Yuan Bai; Yannick Bailly; Kithiganahalli Narayanaswamy Balaji; Walter Balduini; Andrea Ballabio; Rena Balzan; Rajkumar Banerjee; Gábor Bánhegyi; Haijun Bao; Benoit Barbeau; Maria D Barrachina; Esther Barreiro; Bonnie Bartel; Alberto Bartolomé; Diane C Bassham; Maria Teresa Bassi; Robert C Bast; Alakananda Basu; Maria Teresa Batista; Henri Batoko; Maurizio Battino; Kyle Bauckman; Bradley L Baumgarner; K Ulrich Bayer; Rupert Beale; Jean-François Beaulieu; George R Beck; Christoph Becker; J David Beckham; Pierre-André Bédard; Patrick J Bednarski; Thomas J Begley; Christian Behl; Christian Behrends; Georg Mn Behrens; Kevin E Behrns; Eloy Bejarano; Amine Belaid; Francesca Belleudi; Giovanni Bénard; Guy Berchem; Daniele Bergamaschi; Matteo Bergami; Ben Berkhout; Laura Berliocchi; Amélie Bernard; Monique Bernard; Francesca Bernassola; Anne Bertolotti; Amanda S Bess; Sébastien Besteiro; Saverio Bettuzzi; Savita Bhalla; Shalmoli Bhattacharyya; Sujit K Bhutia; Caroline Biagosch; Michele Wolfe Bianchi; Martine Biard-Piechaczyk; Viktor Billes; Claudia Bincoletto; Baris Bingol; Sara W Bird; Marc Bitoun; Ivana Bjedov; Craig Blackstone; Lionel Blanc; Guillermo A Blanco; Heidi Kiil Blomhoff; Emilio Boada-Romero; Stefan Böckler; Marianne Boes; Kathleen Boesze-Battaglia; Lawrence H Boise; Alessandra Bolino; Andrea Boman; Paolo Bonaldo; Matteo Bordi; Jürgen Bosch; Luis M Botana; Joelle Botti; German Bou; Marina Bouché; Marion Bouchecareilh; Marie-Josée Boucher; Michael E Boulton; Sebastien G Bouret; Patricia Boya; Michaël Boyer-Guittaut; Peter V Bozhkov; Nathan Brady; Vania Mm Braga; Claudio Brancolini; Gerhard H Braus; José M Bravo-San Pedro; Lisa A Brennan; Emery H Bresnick; Patrick Brest; Dave Bridges; Marie-Agnès Bringer; Marisa Brini; Glauber C Brito; Bertha Brodin; Paul S Brookes; Eric J Brown; Karen Brown; Hal E Broxmeyer; Alain Bruhat; Patricia Chakur Brum; John H Brumell; Nicola Brunetti-Pierri; Robert J Bryson-Richardson; Shilpa Buch; Alastair M Buchan; Hikmet Budak; Dmitry V Bulavin; Scott J Bultman; Geert Bultynck; Vladimir Bumbasirevic; Yan Burelle; Robert E Burke; Margit Burmeister; Peter Bütikofer; Laura Caberlotto; Ken Cadwell; Monika Cahova; Dongsheng Cai; Jingjing Cai; Qian Cai; Sara Calatayud; Nadine Camougrand; Michelangelo Campanella; Grant R Campbell; Matthew Campbell; Silvia Campello; Robin Candau; Isabella Caniggia; Lavinia Cantoni; Lizhi Cao; Allan B Caplan; Michele Caraglia; Claudio Cardinali; Sandra Morais Cardoso; Jennifer S Carew; Laura A Carleton; Cathleen R Carlin; Silvia Carloni; Sven R Carlsson; Didac Carmona-Gutierrez; Leticia Am Carneiro; Oliana Carnevali; Serena Carra; Alice Carrier; Bernadette Carroll; Caty Casas; Josefina Casas; Giuliana Cassinelli; Perrine Castets; Susana Castro-Obregon; Gabriella Cavallini; Isabella Ceccherini; Francesco Cecconi; Arthur I Cederbaum; Valentín Ceña; Simone Cenci; Claudia Cerella; Davide Cervia; Silvia Cetrullo; Hassan Chaachouay; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Georgios Chamilos; Edmond Yw Chan; Matthew Tv Chan; Dhyan Chandra; Pallavi Chandra; Chih-Peng Chang; Raymond Chuen-Chung Chang; Ta Yuan Chang; John C Chatham; Saurabh Chatterjee; Santosh Chauhan; Yongsheng Che; Michael E Cheetham; Rajkumar Cheluvappa; Chun-Jung Chen; Gang Chen; Guang-Chao Chen; Guoqiang Chen; Hongzhuan Chen; Jeff W Chen; Jian-Kang Chen; Min Chen; Mingzhou Chen; Peiwen Chen; Qi Chen; Quan Chen; Shang-Der Chen; Si Chen; Steve S-L Chen; Wei Chen; Wei-Jung Chen; Wen Qiang Chen; Wenli Chen; Xiangmei Chen; Yau-Hung Chen; Ye-Guang Chen; Yin Chen; Yingyu Chen; Yongshun Chen; Yu-Jen Chen; Yue-Qin Chen; Yujie Chen; Zhen Chen; Zhong Chen; Alan Cheng; Christopher Hk Cheng; Hua Cheng; Heesun Cheong; Sara Cherry; Jason Chesney; Chun Hei Antonio Cheung; Eric Chevet; Hsiang Cheng Chi; Sung-Gil Chi; Fulvio Chiacchiera; Hui-Ling Chiang; Roberto Chiarelli; Mario Chiariello; Marcello Chieppa; Lih-Shen Chin; Mario Chiong; Gigi Nc Chiu; Dong-Hyung Cho; Ssang-Goo Cho; William C Cho; Yong-Yeon Cho; Young-Seok Cho; Augustine Mk Choi; Eui-Ju Choi; Eun-Kyoung Choi; Jayoung Choi; Mary E Choi; Seung-Il Choi; Tsui-Fen Chou; Salem Chouaib; Divaker Choubey; Vinay Choubey; Kuan-Chih Chow; Kamal Chowdhury; Charleen T Chu; Tsung-Hsien Chuang; Taehoon Chun; Hyewon Chung; Taijoon Chung; Yuen-Li Chung; Yong-Joon Chwae; Valentina Cianfanelli; Roberto Ciarcia; Iwona A Ciechomska; Maria Rosa Ciriolo; Mara Cirone; Sofie Claerhout; Michael J Clague; Joan Clària; Peter Gh Clarke; Robert Clarke; Emilio Clementi; Cédric Cleyrat; Miriam Cnop; Eliana M Coccia; Tiziana Cocco; Patrice Codogno; Jörn Coers; Ezra Ew Cohen; David Colecchia; Luisa Coletto; Núria S Coll; Emma Colucci-Guyon; Sergio Comincini; Maria Condello; Katherine L Cook; Graham H Coombs; Cynthia D Cooper; J Mark Cooper; Isabelle Coppens; Maria Tiziana Corasaniti; Marco Corazzari; Ramon Corbalan; Elisabeth Corcelle-Termeau; Mario D Cordero; Cristina Corral-Ramos; Olga Corti; Andrea Cossarizza; Paola Costelli; Safia Costes; Susan L Cotman; Ana Coto-Montes; Sandra Cottet; Eduardo Couve; Lori R Covey; L Ashley Cowart; Jeffery S Cox; Fraser P Coxon; Carolyn B Coyne; Mark S Cragg; Rolf J Craven; Tiziana Crepaldi; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Maria Teresa Cruz; Ana Maria Cuervo; Jose M Cuezva; Taixing Cui; Pedro R Cutillas; Mark J Czaja; Maria F Czyzyk-Krzeska; Ruben K Dagda; Uta Dahmen; Chunsun Dai; Wenjie Dai; Yun Dai; Kevin N Dalby; Luisa Dalla Valle; Guillaume Dalmasso; Marcello D'Amelio; Markus Damme; Arlette Darfeuille-Michaud; Catherine Dargemont; Victor M Darley-Usmar; Srinivasan Dasarathy; Biplab Dasgupta; Srikanta Dash; Crispin R Dass; Hazel Marie Davey; Lester M Davids; David Dávila; Roger J Davis; Ted M Dawson; Valina L Dawson; Paula Daza; Jackie de Belleroche; Paul de Figueiredo; Regina Celia Bressan Queiroz de Figueiredo; José de la Fuente; Luisa De Martino; Antonella De Matteis; Guido Ry De Meyer; Angelo De Milito; Mauro De Santi; Wanderley de Souza; Vincenzo De Tata; Daniela De Zio; Jayanta Debnath; Reinhard Dechant; Jean-Paul Decuypere; Shane Deegan; Benjamin Dehay; Barbara Del Bello; Dominic P Del Re; Régis Delage-Mourroux; Lea Md Delbridge; Louise Deldicque; Elizabeth Delorme-Axford; Yizhen Deng; Joern Dengjel; Melanie Denizot; Paul Dent; Channing J Der; Vojo Deretic; Benoît Derrien; Eric Deutsch; Timothy P Devarenne; Rodney J Devenish; Sabrina Di Bartolomeo; Nicola Di Daniele; Fabio Di Domenico; Alessia Di Nardo; Simone Di Paola; Antonio Di Pietro; Livia Di Renzo; Aaron DiAntonio; Guillermo Díaz-Araya; Ines Díaz-Laviada; Maria T Diaz-Meco; Javier Diaz-Nido; Chad A Dickey; Robert C Dickson; Marc Diederich; Paul Digard; Ivan Dikic; Savithrama P Dinesh-Kumar; Chan Ding; Wen-Xing Ding; Zufeng Ding; Luciana Dini; Jörg Hw Distler; Abhinav Diwan; Mojgan Djavaheri-Mergny; Kostyantyn Dmytruk; Renwick Cj Dobson; Volker Doetsch; Karol Dokladny; Svetlana Dokudovskaya; Massimo Donadelli; X Charlie Dong; Xiaonan Dong; Zheng Dong; Terrence M Donohue; Kelly S Doran; Gabriella D'Orazi; Gerald W Dorn; Victor Dosenko; Sami Dridi; Liat Drucker; Jie Du; Li-Lin Du; Lihuan Du; André du Toit; Priyamvada Dua; Lei Duan; Pu Duann; Vikash Kumar Dubey; Michael R Duchen; Michel A Duchosal; Helene Duez; Isabelle Dugail; Verónica I Dumit; Mara C Duncan; Elaine A Dunlop; William A Dunn; Nicolas Dupont; Luc Dupuis; Raúl V Durán; Thomas M Durcan; Stéphane Duvezin-Caubet; Umamaheswar Duvvuri; Vinay Eapen; Darius Ebrahimi-Fakhari; Arnaud Echard; Leopold Eckhart; Charles L Edelstein; Aimee L Edinger; Ludwig Eichinger; Tobias Eisenberg; Avital Eisenberg-Lerner; N Tony Eissa; Wafik S El-Deiry; Victoria El-Khoury; Zvulun Elazar; Hagit Eldar-Finkelman; Chris Jh Elliott; Enzo Emanuele; Urban Emmenegger; Nikolai Engedal; Anna-Mart Engelbrecht; Simone Engelender; Jorrit M Enserink; Ralf Erdmann; Jekaterina Erenpreisa; Rajaraman Eri; Jason L Eriksen; Andreja Erman; Ricardo Escalante; Eeva-Liisa Eskelinen; Lucile Espert; Lorena Esteban-Martínez; Thomas J Evans; Mario Fabri; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Nils J Færgeman; Alberto Faggioni; W Douglas Fairlie; Chunhai Fan; Daping Fan; Jie Fan; Shengyun Fang; Manolis Fanto; Alessandro Fanzani; Thomas Farkas; Mathias Faure; Francois B Favier; Howard Fearnhead; Massimo Federici; Erkang Fei; Tania C Felizardo; Hua Feng; Yibin Feng; Yuchen Feng; Thomas A Ferguson; Álvaro F Fernández; Maite G Fernandez-Barrena; Jose C Fernandez-Checa; Arsenio Fernández-López; Martin E Fernandez-Zapico; Olivier Feron; Elisabetta Ferraro; Carmen Veríssima Ferreira-Halder; Laszlo Fesus; Ralph Feuer; Fabienne C Fiesel; Eduardo C Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; John H Fingert; Steven Finkbeiner; Toren Finkel; Filomena Fiorito; Paul B Fisher; Marc Flajolet; Flavio Flamigni; Oliver Florey; Salvatore Florio; R Andres Floto; Marco Folini; Carlo Follo; Edward A Fon; Francesco Fornai; Franco Fortunato; Alessandro Fraldi; Rodrigo Franco; Arnaud Francois; Aurélie François; Lisa B Frankel; Iain Dc Fraser; Norbert Frey; Damien G Freyssenet; Christian Frezza; Scott L Friedman; Daniel E Frigo; Dongxu Fu; José M Fuentes; Juan Fueyo; Yoshio Fujitani; Yuuki Fujiwara; Mikihiro Fujiya; Mitsunori Fukuda; Simone Fulda; Carmela Fusco; Bozena Gabryel; Matthias Gaestel; Philippe Gailly; Malgorzata Gajewska; Sehamuddin Galadari; Gad Galili; Inmaculada Galindo; Maria F Galindo; Giovanna Galliciotti; Lorenzo Galluzzi; Luca Galluzzi; Vincent Galy; Noor Gammoh; Sam Gandy; Anand K Ganesan; Swamynathan Ganesan; Ian G Ganley; Monique Gannagé; Fen-Biao Gao; Feng Gao; Jian-Xin Gao; Lorena García Nannig; Eleonora García Véscovi; Marina Garcia-Macía; Carmen Garcia-Ruiz; Abhishek D Garg; Pramod Kumar Garg; Ricardo Gargini; Nils Christian Gassen; Damián Gatica; Evelina Gatti; Julie Gavard; Evripidis Gavathiotis; Liang Ge; Pengfei Ge; Shengfang Ge; Po-Wu Gean; Vania Gelmetti; Armando A Genazzani; Jiefei Geng; Pascal Genschik; Lisa Gerner; Jason E Gestwicki; David A Gewirtz; Saeid Ghavami; Eric Ghigo; Debabrata Ghosh; Anna Maria Giammarioli; Francesca Giampieri; Claudia Giampietri; Alexandra Giatromanolaki; Derrick J Gibbings; Lara Gibellini; Spencer B Gibson; Vanessa Ginet; Antonio Giordano; Flaviano Giorgini; Elisa Giovannetti; Stephen E Girardin; Suzana Gispert; Sandy Giuliano; Candece L Gladson; Alvaro Glavic; Martin Gleave; Nelly Godefroy; Robert M Gogal; Kuppan Gokulan; Gustavo H Goldman; Delia Goletti; Michael S Goligorsky; Aldrin V Gomes; Ligia C Gomes; Hernando Gomez; Candelaria Gomez-Manzano; Rubén Gómez-Sánchez; Dawit Ap Gonçalves; Ebru Goncu; Qingqiu Gong; Céline Gongora; Carlos B Gonzalez; Pedro Gonzalez-Alegre; Pilar Gonzalez-Cabo; Rosa Ana González-Polo; Ing Swie Goping; Carlos Gorbea; Nikolai V Gorbunov; Daphne R Goring; Adrienne M Gorman; Sharon M Gorski; Sandro Goruppi; Shino Goto-Yamada; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Yacine Graba; Martin Graef; Giovanna E Granato; Gary Dean Grant; Steven Grant; Giovanni Luca Gravina; Douglas R Green; Alexander Greenhough; Michael T Greenwood; Benedetto Grimaldi; Frédéric Gros; Charles Grose; Jean-Francois Groulx; Florian Gruber; Paolo Grumati; Tilman Grune; Jun-Lin Guan; Kun-Liang Guan; Barbara Guerra; Carlos Guillen; Kailash Gulshan; Jan Gunst; Chuanyong Guo; Lei Guo; Ming Guo; Wenjie Guo; Xu-Guang Guo; Andrea A Gust; Åsa B Gustafsson; Elaine Gutierrez; Maximiliano G Gutierrez; Ho-Shin Gwak; Albert Haas; James E Haber; Shinji Hadano; Monica Hagedorn; David R Hahn; Andrew J Halayko; Anne Hamacher-Brady; Kozo Hamada; Ahmed Hamai; Andrea Hamann; Maho Hamasaki; Isabelle Hamer; Qutayba Hamid; Ester M Hammond; Feng Han; Weidong Han; James T Handa; John A Hanover; Malene Hansen; Masaru Harada; Ljubica Harhaji-Trajkovic; J Wade Harper; Abdel Halim Harrath; Adrian L Harris; James Harris; Udo Hasler; Peter Hasselblatt; Kazuhisa Hasui; Robert G Hawley; Teresa S Hawley; Congcong He; Cynthia Y He; Fengtian He; Gu He; Rong-Rong He; Xian-Hui He; You-Wen He; Yu-Ying He; Joan K Heath; Marie-Josée Hébert; Robert A Heinzen; Gudmundur Vignir Helgason; Michael Hensel; Elizabeth P Henske; Chengtao Her; Paul K Herman; Agustín Hernández; Carlos Hernandez; Sonia Hernández-Tiedra; Claudio Hetz; P Robin Hiesinger; Katsumi Higaki; Sabine Hilfiker; Bradford G Hill; Joseph A Hill; William D Hill; Keisuke Hino; Daniel Hofius; Paul Hofman; Günter U Höglinger; Jörg Höhfeld; Marina K Holz; Yonggeun Hong; David A Hood; Jeroen Jm Hoozemans; Thorsten Hoppe; Chin Hsu; Chin-Yuan Hsu; Li-Chung Hsu; Dong Hu; Guochang Hu; Hong-Ming Hu; Hongbo Hu; Ming Chang Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Ya Hua; Canhua Huang; Huey-Lan Huang; Kuo-How Huang; Kuo-Yang Huang; Shile Huang; Shiqian Huang; Wei-Pang Huang; Yi-Ran Huang; Yong Huang; Yunfei Huang; Tobias B Huber; Patricia Huebbe; Won-Ki Huh; Juha J Hulmi; Gang Min Hur; James H Hurley; Zvenyslava Husak; Sabah Na Hussain; Salik Hussain; Jung Jin Hwang; Seungmin Hwang; Thomas Is Hwang; Atsuhiro Ichihara; Yuzuru Imai; Carol Imbriano; Megumi Inomata; Takeshi Into; Valentina Iovane; Juan L Iovanna; Renato V Iozzo; Nancy Y Ip; Javier E Irazoqui; Pablo Iribarren; Yoshitaka Isaka; Aleksandra J Isakovic; Harry Ischiropoulos; Jeffrey S Isenberg; Mohammad Ishaq; Hiroyuki Ishida; Isao Ishii; Jane E Ishmael; Ciro Isidoro; Ken-Ichi Isobe; Erika Isono; Shohreh Issazadeh-Navikas; Koji Itahana; Eisuke Itakura; Andrei I Ivanov; Anand Krishnan V Iyer; José M Izquierdo; Yotaro Izumi; Valentina Izzo; Marja Jäättelä; Nadia Jaber; Daniel John Jackson; William T Jackson; Tony George Jacob; Thomas S Jacques; Chinnaswamy Jagannath; Ashish Jain; Nihar Ranjan Jana; Byoung Kuk Jang; Alkesh Jani; Bassam Janji; Paulo Roberto Jannig; Patric J Jansson; Steve Jean; Marina Jendrach; Ju-Hong Jeon; Niels Jessen; Eui-Bae Jeung; Kailiang Jia; Lijun Jia; Hong Jiang; Hongchi Jiang; Liwen Jiang; Teng Jiang; Xiaoyan Jiang; Xuejun Jiang; Xuejun Jiang; Ying Jiang; Yongjun Jiang; Alberto Jiménez; Cheng Jin; Hongchuan Jin; Lei Jin; Meiyan Jin; Shengkan Jin; Umesh Kumar Jinwal; Eun-Kyeong Jo; Terje Johansen; Daniel E Johnson; Gail Vw Johnson; James D Johnson; Eric Jonasch; Chris Jones; Leo Ab Joosten; Joaquin Jordan; Anna-Maria Joseph; Bertrand Joseph; Annie M Joubert; Dianwen Ju; Jingfang Ju; Hsueh-Fen Juan; Katrin Juenemann; Gábor Juhász; Hye Seung Jung; Jae U Jung; Yong-Keun Jung; Heinz Jungbluth; Matthew J Justice; Barry Jutten; Nadeem O Kaakoush; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Bertrand Kaeffer; Katarina Kågedal; Alon Kahana; Shingo Kajimura; Or Kakhlon; Manjula Kalia; Dhan V Kalvakolanu; Yoshiaki Kamada; Konstantinos Kambas; Vitaliy O Kaminskyy; Harm H Kampinga; Mustapha Kandouz; Chanhee Kang; Rui Kang; Tae-Cheon Kang; Tomotake Kanki; Thirumala-Devi Kanneganti; Haruo Kanno; Anumantha G Kanthasamy; Marc Kantorow; Maria Kaparakis-Liaskos; Orsolya Kapuy; Vassiliki Karantza; Md Razaul Karim; Parimal Karmakar; Arthur Kaser; Susmita Kaushik; Thomas Kawula; A Murat Kaynar; Po-Yuan Ke; Zun-Ji Ke; John H Kehrl; Kate E Keller; Jongsook Kim Kemper; Anne K Kenworthy; Oliver Kepp; Andreas Kern; Santosh Kesari; David Kessel; Robin Ketteler; Isis do Carmo Kettelhut; Bilon Khambu; Muzamil Majid Khan; Vinoth Km Khandelwal; Sangeeta Khare; Juliann G Kiang; Amy A Kiger; Akio Kihara; Arianna L Kim; Cheol Hyeon Kim; Deok Ryong Kim; Do-Hyung Kim; Eung Kweon Kim; Hye Young Kim; Hyung-Ryong Kim; Jae-Sung Kim; Jeong Hun Kim; Jin Cheon Kim; Jin Hyoung Kim; Kwang Woon Kim; Michael D Kim; Moon-Moo Kim; Peter K Kim; Seong Who Kim; Soo-Youl Kim; Yong-Sun Kim; Yonghyun Kim; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Jason S King; Karla Kirkegaard; Vladimir Kirkin; Lorrie A Kirshenbaum; Shuji Kishi; Yasuo Kitajima; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Rudolf A Kley; Walter T Klimecki; Michael Klinkenberg; Jochen Klucken; Helene Knævelsrud; Erwin Knecht; Laura Knuppertz; Jiunn-Liang Ko; Satoru Kobayashi; Jan C Koch; Christelle Koechlin-Ramonatxo; Ulrich Koenig; Young Ho Koh; Katja Köhler; Sepp D Kohlwein; Masato Koike; Masaaki Komatsu; Eiki Kominami; Dexin Kong; Hee Jeong Kong; Eumorphia G Konstantakou; Benjamin T Kopp; Tamas Korcsmaros; Laura Korhonen; Viktor I Korolchuk; Nadya V Koshkina; Yanjun Kou; Michael I Koukourakis; Constantinos Koumenis; Attila L Kovács; Tibor Kovács; Werner J Kovacs; Daisuke Koya; Claudine Kraft; Dimitri Krainc; Helmut Kramer; Tamara Kravic-Stevovic; Wilhelm Krek; Carole Kretz-Remy; Roswitha Krick; Malathi Krishnamurthy; Janos Kriston-Vizi; Guido Kroemer; Michael C Kruer; Rejko Kruger; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Christian Kuhn; Addanki Pratap Kumar; Anuj Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Rakesh Kumar; Sharad Kumar; Mondira Kundu; Hsing-Jien Kung; Atsushi Kuno; Sheng-Han Kuo; Jeff Kuret; Tino Kurz; Terry Kwok; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert R La Spada; Frank Lafont; Tim Lahm; Aparna Lakkaraju; Truong Lam; Trond Lamark; Steve Lancel; Terry H Landowski; Darius J R Lane; Jon D Lane; Cinzia Lanzi; Pierre Lapaquette; Louis R Lapierre; Jocelyn Laporte; Johanna Laukkarinen; Gordon W Laurie; Sergio Lavandero; Lena Lavie; Matthew J LaVoie; Betty Yuen Kwan Law; Helen Ka-Wai Law; Kelsey B Law; Robert Layfield; Pedro A Lazo; Laurent Le Cam; Karine G Le Roch; Hervé Le Stunff; Vijittra Leardkamolkarn; Marc Lecuit; Byung-Hoon Lee; Che-Hsin Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Hsinyu Lee; Jae Keun Lee; Jongdae Lee; Ju-Hyun Lee; Jun Hee Lee; Michael Lee; Myung-Shik Lee; Patty J Lee; Sam W Lee; Seung-Jae Lee; Shiow-Ju Lee; Stella Y Lee; Sug Hyung Lee; Sung Sik Lee; Sung-Joon Lee; Sunhee Lee; Ying-Ray Lee; Yong J Lee; Young H Lee; Christiaan Leeuwenburgh; Sylvain Lefort; Renaud Legouis; Jinzhi Lei; Qun-Ying Lei; David A Leib; Gil Leibowitz; Istvan Lekli; Stéphane D Lemaire; John J Lemasters; Marius K Lemberg; Antoinette Lemoine; Shuilong Leng; Guido Lenz; Paola Lenzi; Lilach O Lerman; Daniele Lettieri Barbato; Julia I-Ju Leu; Hing Y Leung; Beth Levine; Patrick A Lewis; Frank Lezoualc'h; Chi Li; Faqiang Li; Feng-Jun Li; Jun Li; Ke Li; Lian Li; Min Li; Min Li; Qiang Li; Rui Li; Sheng Li; Wei Li; Wei Li; Xiaotao Li; Yumin Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Yulin Liao; Joana Liberal; Pawel P Liberski; Pearl Lie; Andrew P Lieberman; Hyunjung Jade Lim; Kah-Leong Lim; Kyu Lim; Raquel T Lima; Chang-Shen Lin; Chiou-Feng Lin; Fang Lin; Fangming Lin; Fu-Cheng Lin; Kui Lin; Kwang-Huei Lin; Pei-Hui Lin; Tianwei Lin; Wan-Wan Lin; Yee-Shin Lin; Yong Lin; Rafael Linden; Dan Lindholm; Lisa M Lindqvist; Paul Lingor; Andreas Linkermann; Lance A Liotta; Marta M Lipinski; Vitor A Lira; Michael P Lisanti; Paloma B Liton; Bo Liu; Chong Liu; Chun-Feng Liu; Fei Liu; Hung-Jen Liu; Jianxun Liu; Jing-Jing Liu; Jing-Lan Liu; Ke Liu; Leyuan Liu; Liang Liu; Quentin Liu; Rong-Yu Liu; Shiming Liu; Shuwen Liu; Wei Liu; Xian-De Liu; Xiangguo Liu; Xiao-Hong Liu; Xinfeng Liu; Xu Liu; Xueqin Liu; Yang Liu; Yule Liu; Zexian Liu; Zhe Liu; Juan P Liuzzi; Gérard Lizard; Mila Ljujic; Irfan J Lodhi; Susan E Logue; Bal L Lokeshwar; Yun Chau Long; Sagar Lonial; Benjamin Loos; Carlos López-Otín; Cristina López-Vicario; Mar Lorente; Philip L Lorenzi; Péter Lõrincz; Marek Los; Michael T Lotze; Penny E Lovat; Binfeng Lu; Bo Lu; Jiahong Lu; Qing Lu; She-Min Lu; Shuyan Lu; Yingying Lu; Frédéric Luciano; Shirley Luckhart; John Milton Lucocq; Paula Ludovico; Aurelia Lugea; Nicholas W Lukacs; Julian J Lum; Anders H Lund; Honglin Luo; Jia Luo; Shouqing Luo; Claudio Luparello; Timothy Lyons; Jianjie Ma; Yi Ma; Yong Ma; Zhenyi Ma; Juliano Machado; Glaucia M Machado-Santelli; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; John D MacMicking; Lee Ann MacMillan-Crow; Frank Madeo; Muniswamy Madesh; Julio Madrigal-Matute; Akiko Maeda; Tatsuya Maeda; Gustavo Maegawa; Emilia Maellaro; Hannelore Maes; Marta Magariños; Kenneth Maiese; Tapas K Maiti; Luigi Maiuri; Maria Chiara Maiuri; Carl G Maki; Roland Malli; Walter Malorni; Alina Maloyan; Fathia Mami-Chouaib; Na Man; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Serge N Manié; Claudia Manzoni; Kai Mao; Zixu Mao; Zong-Wan Mao; Philippe Marambaud; Anna Maria Marconi; Zvonimir Marelja; Gabriella Marfe; Marta Margeta; Eva Margittai; Muriel Mari; Francesca V Mariani; Concepcio Marin; Sara Marinelli; Guillermo Mariño; Ivanka Markovic; Rebecca Marquez; Alberto M Martelli; Sascha Martens; Katie R Martin; Seamus J Martin; Shaun Martin; Miguel A Martin-Acebes; Paloma Martín-Sanz; Camille Martinand-Mari; Wim Martinet; Jennifer Martinez; Nuria Martinez-Lopez; Ubaldo Martinez-Outschoorn; Moisés Martínez-Velázquez; Marta Martinez-Vicente; Waleska Kerllen Martins; Hirosato Mashima; James A Mastrianni; Giuseppe Matarese; Paola Matarrese; Roberto Mateo; Satoaki Matoba; Naomichi Matsumoto; Takehiko Matsushita; Akira Matsuura; Takeshi Matsuzawa; Mark P Mattson; Soledad Matus; Norma Maugeri; Caroline Mauvezin; Andreas Mayer; Dusica Maysinger; Guillermo D Mazzolini; Mary Kate McBrayer; Kimberly McCall; Craig McCormick; Gerald M McInerney; Skye C McIver; Sharon McKenna; John J McMahon; Iain A McNeish; Fatima Mechta-Grigoriou; Jan Paul Medema; Diego L Medina; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Yide Mei; Ute-Christiane Meier; Alfred J Meijer; Alicia Meléndez; Gerry Melino; Sonia Melino; Edesio Jose Tenorio de Melo; Maria A Mena; Marc D Meneghini; Javier A Menendez; Regina Menezes; Liesu Meng; Ling-Hua Meng; Songshu Meng; Rossella Menghini; A Sue Menko; Rubem Fs Menna-Barreto; Manoj B Menon; Marco A Meraz-Ríos; Giuseppe Merla; Luciano Merlini; Angelica M Merlot; Andreas Meryk; Stefania Meschini; Joel N Meyer; Man-Tian Mi; Chao-Yu Miao; Lucia Micale; Simon Michaeli; Carine Michiels; Anna Rita Migliaccio; Anastasia Susie Mihailidou; Dalibor Mijaljica; Katsuhiko Mikoshiba; Enrico Milan; Leonor Miller-Fleming; Gordon B Mills; Ian G Mills; Georgia Minakaki; Berge A Minassian; Xiu-Fen Ming; Farida Minibayeva; Elena A Minina; Justine D Mintern; Saverio Minucci; Antonio Miranda-Vizuete; Claire H Mitchell; Shigeki Miyamoto; Keisuke Miyazawa; Noboru Mizushima; Katarzyna Mnich; Baharia Mograbi; Simin Mohseni; Luis Ferreira Moita; Marco Molinari; Maurizio Molinari; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Marco Mongillo; Martha M Monick; Serena Montagnaro; Craig Montell; Darren J Moore; Michael N Moore; Rodrigo Mora-Rodriguez; Paula I Moreira; Etienne Morel; Maria Beatrice Morelli; Sandra Moreno; Michael J Morgan; Arnaud Moris; Yuji Moriyasu; Janna L Morrison; Lynda A Morrison; Eugenia Morselli; Jorge Moscat; Pope L Moseley; Serge Mostowy; Elisa Motori; Denis Mottet; Jeremy C Mottram; Charbel E-H Moussa; Vassiliki E Mpakou; Hasan Mukhtar; Jean M Mulcahy Levy; Sylviane Muller; Raquel Muñoz-Moreno; Cristina Muñoz-Pinedo; Christian Münz; Maureen E Murphy; James T Murray; Aditya Murthy; Indira U Mysorekar; Ivan R Nabi; Massimo Nabissi; Gustavo A Nader; Yukitoshi Nagahara; Yoshitaka Nagai; Kazuhiro Nagata; Anika Nagelkerke; Péter Nagy; Samisubbu R Naidu; Sreejayan Nair; Hiroyasu Nakano; Hitoshi Nakatogawa; Meera Nanjundan; Gennaro Napolitano; Naweed I Naqvi; Roberta Nardacci; Derek P Narendra; Masashi Narita; Anna Chiara Nascimbeni; Ramesh Natarajan; Luiz C Navegantes; Steffan T Nawrocki; Taras Y Nazarko; Volodymyr Y Nazarko; Thomas Neill; Luca M Neri; Mihai G Netea; Romana T Netea-Maier; Bruno M Neves; Paul A Ney; Ioannis P Nezis; Hang Tt Nguyen; Huu Phuc Nguyen; Anne-Sophie Nicot; Hilde Nilsen; Per Nilsson; Mikio Nishimura; Ichizo Nishino; Mireia Niso-Santano; Hua Niu; Ralph A Nixon; Vincent Co Njar; Takeshi Noda; Angelika A Noegel; Elsie Magdalena Nolte; Erik Norberg; Koenraad K Norga; Sakineh Kazemi Noureini; Shoji Notomi; Lucia Notterpek; Karin Nowikovsky; Nobuyuki Nukina; Thorsten Nürnberger; Valerie B O'Donnell; Tracey O'Donovan; Peter J O'Dwyer; Ina Oehme; Clara L Oeste; Michinaga Ogawa; Besim Ogretmen; Yuji Ogura; Young J Oh; Masaki Ohmuraya; Takayuki Ohshima; Rani Ojha; Koji Okamoto; Toshiro Okazaki; F Javier Oliver; Karin Ollinger; Stefan Olsson; Daniel P Orban; Paulina Ordonez; Idil Orhon; Laszlo Orosz; Eyleen J O'Rourke; Helena Orozco; Angel L Ortega; Elena Ortona; Laura D Osellame; Junko Oshima; Shigeru Oshima; Heinz D Osiewacz; Takanobu Otomo; Kinya Otsu; Jing-Hsiung James Ou; Tiago F Outeiro; Dong-Yun Ouyang; Hongjiao Ouyang; Michael Overholtzer; Michelle A Ozbun; P Hande Ozdinler; Bulent Ozpolat; Consiglia Pacelli; Paolo Paganetti; Guylène Page; Gilles Pages; Ugo Pagnini; Beata Pajak; Stephen C Pak; Karolina Pakos-Zebrucka; Nazzy Pakpour; Zdena Palková; Francesca Palladino; Kathrin Pallauf; Nicolas Pallet; Marta Palmieri; Søren R Paludan; Camilla Palumbo; Silvia Palumbo; Olatz Pampliega; Hongming Pan; Wei Pan; Theocharis Panaretakis; Aseem Pandey; Areti Pantazopoulou; Zuzana Papackova; Daniela L Papademetrio; Issidora Papassideri; Alessio Papini; Nirmala Parajuli; Julian Pardo; Vrajesh V Parekh; Giancarlo Parenti; Jong-In Park; Junsoo Park; Ohkmae K Park; Roy Parker; Rosanna Parlato; Jan B Parys; Katherine R Parzych; Jean-Max Pasquet; Benoit Pasquier; Kishore Bs Pasumarthi; Daniel Patschan; Cam Patterson; Sophie Pattingre; Scott Pattison; Arnim Pause; Hermann Pavenstädt; Flaminia Pavone; Zully Pedrozo; Fernando J Peña; Miguel A Peñalva; Mario Pende; Jianxin Peng; Fabio Penna; Josef M Penninger; Anna Pensalfini; Salvatore Pepe; Gustavo Js Pereira; Paulo C Pereira; Verónica Pérez-de la Cruz; María Esther Pérez-Pérez; Diego Pérez-Rodríguez; Dolores Pérez-Sala; Celine Perier; Andras Perl; David H Perlmutter; Ida Perrotta; Shazib Pervaiz; Maija Pesonen; Jeffrey E Pessin; Godefridus J Peters; Morten Petersen; Irina Petrache; Basil J Petrof; Goran Petrovski; James M Phang; Mauro Piacentini; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Federico Pietrocola; Felipe X Pimentel-Muiños; Mario Pinar; Benjamin Pineda; Ronit Pinkas-Kramarski; Marcello Pinti; Paolo Pinton; Bilal Piperdi; James M Piret; Leonidas C Platanias; Harald W Platta; Edward D Plowey; Stefanie Pöggeler; Marc Poirot; Peter Polčic; Angelo Poletti; Audrey H Poon; Hana Popelka; Blagovesta Popova; Izabela Poprawa; Shibu M Poulose; Joanna Poulton; Scott K Powers; Ted Powers; Mercedes Pozuelo-Rubio; Krisna Prak; Reinhild Prange; Mark Prescott; Muriel Priault; Sharon Prince; Richard L Proia; Tassula Proikas-Cezanne; Holger Prokisch; Vasilis J Promponas; Karin Przyklenk; Rosa Puertollano; Subbiah Pugazhenthi; Luigi Puglielli; Aurora Pujol; Julien Puyal; Dohun Pyeon; Xin Qi; Wen-Bin Qian; Zheng-Hong Qin; Yu Qiu; Ziwei Qu; Joe Quadrilatero; Frederick Quinn; Nina Raben; Hannah Rabinowich; Flavia Radogna; Michael J Ragusa; Mohamed Rahmani; Komal Raina; Sasanka Ramanadham; Rajagopal Ramesh; Abdelhaq Rami; Sarron Randall-Demllo; Felix Randow; Hai Rao; V Ashutosh Rao; Blake B Rasmussen; Tobias M Rasse; Edward A Ratovitski; Pierre-Emmanuel Rautou; Swapan K Ray; Babak Razani; Bruce H Reed; Fulvio Reggiori; Markus Rehm; Andreas S Reichert; Theo Rein; David J Reiner; Eric Reits; Jun Ren; Xingcong Ren; Maurizio Renna; Jane Eb Reusch; Jose L Revuelta; Leticia Reyes; Alireza R Rezaie; Robert I Richards; Des R Richardson; Clémence Richetta; Michael A Riehle; Bertrand H Rihn; Yasuko Rikihisa; Brigit E Riley; Gerald Rimbach; Maria Rita Rippo; Konstantinos Ritis; Federica Rizzi; Elizete Rizzo; Peter J Roach; Jeffrey Robbins; Michel Roberge; Gabriela Roca; Maria Carmela Roccheri; Sonia Rocha; Cecilia Mp Rodrigues; Clara I Rodríguez; Santiago Rodriguez de Cordoba; Natalia Rodriguez-Muela; Jeroen Roelofs; Vladimir V Rogov; Troy T Rohn; Bärbel Rohrer; Davide Romanelli; Luigina Romani; Patricia Silvia Romano; M Isabel G Roncero; Jose Luis Rosa; Alicia Rosello; Kirill V Rosen; Philip Rosenstiel; Magdalena Rost-Roszkowska; Kevin A Roth; Gael Roué; Mustapha Rouis; Kasper M Rouschop; Daniel T Ruan; Diego Ruano; David C Rubinsztein; Edmund B Rucker; Assaf Rudich; Emil Rudolf; Ruediger Rudolf; Markus A Ruegg; Carmen Ruiz-Roldan; Avnika Ashok Ruparelia; Paola Rusmini; David W Russ; Gian Luigi Russo; Giuseppe Russo; Rossella Russo; Tor Erik Rusten; Victoria Ryabovol; Kevin M Ryan; Stefan W Ryter; David M Sabatini; Michael Sacher; Carsten Sachse; Michael N Sack; Junichi Sadoshima; Paul Saftig; Ronit Sagi-Eisenberg; Sumit Sahni; Pothana Saikumar; Tsunenori Saito; Tatsuya Saitoh; Koichi Sakakura; Machiko Sakoh-Nakatogawa; Yasuhito Sakuraba; María Salazar-Roa; Paolo Salomoni; Ashok K Saluja; Paul M Salvaterra; Rosa Salvioli; Afshin Samali; Anthony Mj Sanchez; José A Sánchez-Alcázar; Ricardo Sanchez-Prieto; Marco Sandri; Miguel A Sanjuan; Stefano Santaguida; Laura Santambrogio; Giorgio Santoni; Claudia Nunes Dos Santos; Shweta Saran; Marco Sardiello; Graeme Sargent; Pallabi Sarkar; Sovan Sarkar; Maria Rosa Sarrias; Minnie M Sarwal; Chihiro Sasakawa; Motoko Sasaki; Miklos Sass; Ken Sato; Miyuki Sato; Joseph Satriano; Niramol Savaraj; Svetlana Saveljeva; Liliana Schaefer; Ulrich E Schaible; Michael Scharl; Hermann M Schatzl; Randy Schekman; Wiep Scheper; Alfonso Schiavi; Hyman M Schipper; Hana Schmeisser; Jens Schmidt; Ingo Schmitz; Bianca E Schneider; E Marion Schneider; Jaime L Schneider; Eric A Schon; Miriam J Schönenberger; Axel H Schönthal; Daniel F Schorderet; Bernd Schröder; Sebastian Schuck; Ryan J Schulze; Melanie Schwarten; Thomas L Schwarz; Sebastiano Sciarretta; Kathleen Scotto; A Ivana Scovassi; Robert A Screaton; Mark Screen; Hugo Seca; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Jose M Seguí-Simarro; Juan Segura-Aguilar; Ekihiro Seki; Christian Sell; Iban Seiliez; Clay F Semenkovich; Gregg L Semenza; Utpal Sen; Andreas L Serra; Ana Serrano-Puebla; Hiromi Sesaki; Takao Setoguchi; Carmine Settembre; John J Shacka; Ayesha N Shajahan-Haq; Irving M Shapiro; Shweta Sharma; Hua She; C-K James Shen; Chiung-Chyi Shen; Han-Ming Shen; Sanbing Shen; Weili Shen; Rui Sheng; Xianyong Sheng; Zu-Hang Sheng; Trevor G Shepherd; Junyan Shi; Qiang Shi; Qinghua Shi; Yuguang Shi; Shusaku Shibutani; Kenichi Shibuya; Yoshihiro Shidoji; Jeng-Jer Shieh; Chwen-Ming Shih; Yohta Shimada; Shigeomi Shimizu; Dong Wook Shin; Mari L Shinohara; Michiko Shintani; Takahiro Shintani; Tetsuo Shioi; Ken Shirabe; Ronit Shiri-Sverdlov; Orian Shirihai; Gordon C Shore; Chih-Wen Shu; Deepak Shukla; Andriy A Sibirny; Valentina Sica; Christina J Sigurdson; Einar M Sigurdsson; Puran Singh Sijwali; Beata Sikorska; Wilian A Silveira; Sandrine Silvente-Poirot; Gary A Silverman; Jan Simak; Thomas Simmet; Anna Katharina Simon; Hans-Uwe Simon; Cristiano Simone; Matias Simons; Anne Simonsen; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Debasish Sinha; Sangita Sinha; Frank A Sinicrope; Agnieszka Sirko; Kapil Sirohi; Balindiwe Jn Sishi; Annie Sittler; Parco M Siu; Efthimios Sivridis; Anna Skwarska; Ruth Slack; Iva Slaninová; Nikolai Slavov; Soraya S Smaili; Keiran Sm Smalley; Duncan R Smith; Stefaan J Soenen; Scott A Soleimanpour; Anita Solhaug; Kumaravel Somasundaram; Jin H Son; Avinash Sonawane; Chunjuan Song; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Wei Song; Kai Y Soo; Anil K Sood; Tuck Wah Soong; Virawudh Soontornniyomkij; Maurizio Sorice; Federica Sotgia; David R Soto-Pantoja; Areechun Sotthibundhu; Maria João Sousa; Herman P Spaink; Paul N Span; Anne Spang; Janet D Sparks; Peter G Speck; Stephen A Spector; Claudia D Spies; Wolfdieter Springer; Daret St Clair; Alessandra Stacchiotti; Bart Staels; Michael T Stang; Daniel T Starczynowski; Petro Starokadomskyy; Clemens Steegborn; John W Steele; Leonidas Stefanis; Joan Steffan; Christine M Stellrecht; Harald Stenmark; Tomasz M Stepkowski; Stęphan T Stern; Craig Stevens; Brent R Stockwell; Veronika Stoka; Zuzana Storchova; Björn Stork; Vassilis Stratoulias; Dimitrios J Stravopodis; Pavel Strnad; Anne Marie Strohecker; Anna-Lena Ström; Per Stromhaug; Jiri Stulik; Yu-Xiong Su; Zhaoliang Su; Carlos S Subauste; Srinivasa Subramaniam; Carolyn M Sue; Sang Won Suh; Xinbing Sui; Supawadee Sukseree; David Sulzer; Fang-Lin Sun; Jiaren Sun; Jun Sun; Shi-Yong Sun; Yang Sun; Yi Sun; Yingjie Sun; Vinod Sundaramoorthy; Joseph Sung; Hidekazu Suzuki; Kuninori Suzuki; Naoki Suzuki; Tadashi Suzuki; Yuichiro J Suzuki; Michele S Swanson; Charles Swanton; Karl Swärd; Ghanshyam Swarup; Sean T Sweeney; Paul W Sylvester; Zsuzsanna Szatmari; Eva Szegezdi; Peter W Szlosarek; Heinrich Taegtmeyer; Marco Tafani; Emmanuel Taillebourg; Stephen Wg Tait; Krisztina Takacs-Vellai; Yoshinori Takahashi; Szabolcs Takáts; Genzou Takemura; Nagio Takigawa; Nicholas J Talbot; Elena Tamagno; Jerome Tamburini; Cai-Ping Tan; Lan Tan; Mei Lan Tan; Ming Tan; Yee-Joo Tan; Keiji Tanaka; Masaki Tanaka; Daolin Tang; Dingzhong Tang; Guomei Tang; Isei Tanida; Kunikazu Tanji; Bakhos A Tannous; Jose A Tapia; Inmaculada Tasset-Cuevas; Marc Tatar; Iman Tavassoly; Nektarios Tavernarakis; Allen Taylor; Graham S Taylor; Gregory A Taylor; J Paul Taylor; Mark J Taylor; Elena V Tchetina; Andrew R Tee; Fatima Teixeira-Clerc; Sucheta Telang; Tewin Tencomnao; Ba-Bie Teng; Ru-Jeng Teng; Faraj Terro; Gianluca Tettamanti; Arianne L Theiss; Anne E Theron; Kelly Jean Thomas; Marcos P Thomé; Paul G Thomes; Andrew Thorburn; Jeremy Thorner; Thomas Thum; Michael Thumm; Teresa Lm Thurston; Ling Tian; Andreas Till; Jenny Pan-Yun Ting; Vladimir I Titorenko; Lilach Toker; Stefano Toldo; Sharon A Tooze; Ivan Topisirovic; Maria Lyngaas Torgersen; Liliana Torosantucci; Alicia Torriglia; Maria Rosaria Torrisi; Cathy Tournier; Roberto Towns; Vladimir Trajkovic; Leonardo H Travassos; Gemma Triola; Durga Nand Tripathi; Daniela Trisciuoglio; Rodrigo Troncoso; Ioannis P Trougakos; Anita C Truttmann; Kuen-Jer Tsai; Mario P Tschan; Yi-Hsin Tseng; Takayuki Tsukuba; Allan Tsung; Andrey S Tsvetkov; Shuiping Tu; Hsing-Yu Tuan; Marco Tucci; David A Tumbarello; Boris Turk; Vito Turk; Robin Fb Turner; Anders A Tveita; Suresh C Tyagi; Makoto Ubukata; Yasuo Uchiyama; Andrej Udelnow; Takashi Ueno; Midori Umekawa; Rika Umemiya-Shirafuji; Benjamin R Underwood; Christian Ungermann; Rodrigo P Ureshino; Ryo Ushioda; Vladimir N Uversky; Néstor L Uzcátegui; Thomas Vaccari; Maria I Vaccaro; Libuše Váchová; Helin Vakifahmetoglu-Norberg; Rut Valdor; Enza Maria Valente; Francois Vallette; Angela M Valverde; Greet Van den Berghe; Ludo Van Den Bosch; Gijs R van den Brink; F Gisou van der Goot; Ida J van der Klei; Luc Jw van der Laan; Wouter G van Doorn; Marjolein van Egmond; Kenneth L van Golen; Luc Van Kaer; Menno van Lookeren Campagne; Peter Vandenabeele; Wim Vandenberghe; Ilse Vanhorebeek; Isabel Varela-Nieto; M Helena Vasconcelos; Radovan Vasko; Demetrios G Vavvas; Ignacio Vega-Naredo; Guillermo Velasco; Athanassios D Velentzas; Panagiotis D Velentzas; Tibor Vellai; Edo Vellenga; Mikkel Holm Vendelbo; Kartik Venkatachalam; Natascia Ventura; Salvador Ventura; Patrícia St Veras; Mireille Verdier; Beata G Vertessy; Andrea Viale; Michel Vidal; Helena L A Vieira; Richard D Vierstra; Nadarajah Vigneswaran; Neeraj Vij; Miquel Vila; Margarita Villar; Victor H Villar; Joan Villarroya; Cécile Vindis; Giampietro Viola; Maria Teresa Viscomi; Giovanni Vitale; Dan T Vogl; Olga V Voitsekhovskaja; Clarissa von Haefen; Karin von Schwarzenberg; Daniel E Voth; Valérie Vouret-Craviari; Kristina Vuori; Jatin M Vyas; Christian Waeber; Cheryl Lyn Walker; Mark J Walker; Jochen Walter; Lei Wan; Xiangbo Wan; Bo Wang; Caihong Wang; Chao-Yung Wang; Chengshu Wang; Chenran Wang; Chuangui Wang; Dong Wang; Fen Wang; Fuxin Wang; Guanghui Wang; Hai-Jie Wang; Haichao Wang; Hong-Gang Wang; Hongmin Wang; Horng-Dar Wang; Jing Wang; Junjun Wang; Mei Wang; Mei-Qing Wang; Pei-Yu Wang; Peng Wang; Richard C Wang; Shuo Wang; Ting-Fang Wang; Xian Wang; Xiao-Jia Wang; Xiao-Wei Wang; Xin Wang; Xuejun Wang; Yan Wang; Yanming Wang; Ying Wang; Ying-Jan Wang; Yipeng Wang; Yu Wang; Yu Tian Wang; Yuqing Wang; Zhi-Nong Wang; Pablo Wappner; Carl Ward; Diane McVey Ward; Gary Warnes; Hirotaka Watada; Yoshihisa Watanabe; Kei Watase; Timothy E Weaver; Colin D Weekes; Jiwu Wei; Thomas Weide; Conrad C Weihl; Günther Weindl; Simone Nardin Weis; Longping Wen; Xin Wen; Yunfei Wen; Benedikt Westermann; Cornelia M Weyand; Anthony R White; Eileen White; J Lindsay Whitton; Alexander J Whitworth; Joëlle Wiels; Franziska Wild; Manon E Wildenberg; Tom Wileman; Deepti Srinivas Wilkinson; Simon Wilkinson; Dieter Willbold; Chris Williams; Katherine Williams; Peter R Williamson; Konstanze F Winklhofer; Steven S Witkin; Stephanie E Wohlgemuth; Thomas Wollert; Ernst J Wolvetang; Esther Wong; G William Wong; Richard W Wong; Vincent Kam Wai Wong; Elizabeth A Woodcock; Karen L Wright; Chunlai Wu; Defeng Wu; Gen Sheng Wu; Jian Wu; Junfang Wu; Mian Wu; Min Wu; Shengzhou Wu; William Kk Wu; Yaohua Wu; Zhenlong Wu; Cristina Pr Xavier; Ramnik J Xavier; Gui-Xian Xia; Tian Xia; Weiliang Xia; Yong Xia; Hengyi Xiao; Jian Xiao; Shi Xiao; Wuhan Xiao; Chuan-Ming Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Yuyan Xiong; Chuanshan Xu; Congfeng Xu; Feng Xu; Haoxing Xu; Hongwei Xu; Jian Xu; Jianzhen Xu; Jinxian Xu; Liang Xu; Xiaolei Xu; Yangqing Xu; Ye Xu; Zhi-Xiang Xu; Ziheng Xu; Yu Xue; Takahiro Yamada; Ai Yamamoto; Koji Yamanaka; Shunhei Yamashina; Shigeko Yamashiro; Bing Yan; Bo Yan; Xianghua Yan; Zhen Yan; Yasuo Yanagi; Dun-Sheng Yang; Jin-Ming Yang; Liu Yang; Minghua Yang; Pei-Ming Yang; Peixin Yang; Qian Yang; Wannian Yang; Wei Yuan Yang; Xuesong Yang; Yi Yang; Ying Yang; Zhifen Yang; Zhihong Yang; Meng-Chao Yao; Pamela J Yao; Xiaofeng Yao; Zhenyu Yao; Zhiyuan Yao; Linda S Yasui; Mingxiang Ye; Barry Yedvobnick; Behzad Yeganeh; Elizabeth S Yeh; Patricia L Yeyati; Fan Yi; Long Yi; Xiao-Ming Yin; Calvin K Yip; Yeong-Min Yoo; Young Hyun Yoo; Seung-Yong Yoon; Ken-Ichi Yoshida; Tamotsu Yoshimori; Ken H Young; Huixin Yu; Jane J Yu; Jin-Tai Yu; Jun Yu; Li Yu; W Haung Yu; Xiao-Fang Yu; Zhengping Yu; Junying Yuan; Zhi-Min Yuan; Beatrice Yjt Yue; Jianbo Yue; Zhenyu Yue; David N Zacks; Eldad Zacksenhaus; Nadia Zaffaroni; Tania Zaglia; Zahra Zakeri; Vincent Zecchini; Jinsheng Zeng; Min Zeng; Qi Zeng; Antonis S Zervos; Donna D Zhang; Fan Zhang; Guo Zhang; Guo-Chang Zhang; Hao Zhang; Hong Zhang; Hong Zhang; Hongbing Zhang; Jian Zhang; Jian Zhang; Jiangwei Zhang; Jianhua Zhang; Jing-Pu Zhang; Li Zhang; Lin Zhang; Lin Zhang; Long Zhang; Ming-Yong Zhang; Xiangnan Zhang; Xu Dong Zhang; Yan Zhang; Yang Zhang; Yanjin Zhang; Yingmei Zhang; Yunjiao Zhang; Mei Zhao; Wei-Li Zhao; Xiaonan Zhao; Yan G Zhao; Ying Zhao; Yongchao Zhao; Yu-Xia Zhao; Zhendong Zhao; Zhizhuang J Zhao; Dexian Zheng; Xi-Long Zheng; Xiaoxiang Zheng; Boris Zhivotovsky; Qing Zhong; Guang-Zhou Zhou; Guofei Zhou; Huiping Zhou; Shu-Feng Zhou; Xu-Jie Zhou; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Wenhua Zhu; Xiao-Feng Zhu; Yuhua Zhu; Shi-Mei Zhuang; Xiaohong Zhuang; Elio Ziparo; Christos E Zois; Teresa Zoladek; Wei-Xing Zong; Antonio Zorzano; Susu M Zughaier Journal: Autophagy Date: 2016 Impact factor: 16.016